id	sid	tid	token	lemma	pos
gra-1903	1	1	background	background	NOUN
gra-1903	1	2	lung	lung	NOUN
gra-1903	1	3	cancer	cancer	NOUN
gra-1903	1	4	is	be	AUX
gra-1903	1	5	a	a	DET
gra-1903	1	6	major	major	ADJ
gra-1903	1	7	cause	cause	NOUN
gra-1903	1	8	of	of	ADP
gra-1903	1	9	cancer	cancer	NOUN
gra-1903	1	10	related	relate	VERB
gra-1903	1	11	mortality	mortality	NOUN
gra-1903	1	12	.	.	PUNCT
gra-1903	2	1	1about	1about	NUM
gra-1903	2	2	85	85	NUM
gra-1903	2	3	%	%	NOUN
gra-1903	2	4	of	of	ADP
gra-1903	2	5	cases	case	NOUN
gra-1903	2	6	are	be	AUX
gra-1903	2	7	related	relate	VERB
gra-1903	2	8	to	to	ADP
gra-1903	2	9	cigarette	cigarette	NOUN
gra-1903	2	10	smoking	smoking	NOUN
gra-1903	2	11	.	.	PUNCT
gra-1903	3	1	biological	biological	ADJ
gra-1903	3	2	markers	marker	NOUN
gra-1903	3	3	known	know	VERB
gra-1903	3	4	as	as	ADP
gra-1903	3	5	tumour	tumour	ADJ
gra-1903	3	6	markers	marker	NOUN
gra-1903	3	7	are	be	AUX
gra-1903	3	8	used	use	VERB
gra-1903	3	9	as	as	ADP
gra-1903	3	10	predictors	predictor	NOUN
gra-1903	3	11	of	of	ADP
gra-1903	3	12	response	response	NOUN
gra-1903	3	13	to	to	ADP
gra-1903	3	14	treatment	treatment	NOUN
gra-1903	3	15	in	in	ADP
gra-1903	3	16	several	several	ADJ
gra-1903	3	17	types	type	NOUN
gra-1903	3	18	of	of	ADP
gra-1903	3	19	malignant	malignant	ADJ
gra-1903	3	20	tumours	tumour	NOUN
gra-1903	3	21	including	include	VERB
gra-1903	3	22	lung	lung	NOUN
gra-1903	3	23	cancer	cancer	NOUN
gra-1903	3	24	.	.	PUNCT
gra-1903	4	1	serial	serial	ADJ
gra-1903	4	2	estimation	estimation	NOUN
gra-1903	4	3	helps	help	VERB
gra-1903	4	4	in	in	ADP
gra-1903	4	5	estimating	estimate	VERB
gra-1903	4	6	the	the	DET
gra-1903	4	7	response	response	NOUN
gra-1903	4	8	to	to	ADP
gra-1903	4	9	treatment	treatment	NOUN
gra-1903	4	10	,	,	PUNCT
gra-1903	4	11	monitoring	monitor	VERB
gra-1903	4	12	the	the	DET
gra-1903	4	13	course	course	NOUN
gra-1903	4	14	of	of	ADP
gra-1903	4	15	the	the	DET
gra-1903	4	16	disease	disease	NOUN
gra-1903	4	17	,	,	PUNCT
gra-1903	4	18	predicting	predict	VERB
gra-1903	4	19	survival	survival	NOUN
gra-1903	4	20	rate	rate	NOUN
gra-1903	4	21	,	,	PUNCT
gra-1903	4	22	surveillance	surveillance	NOUN
gra-1903	4	23	for	for	ADP
gra-1903	4	24	2recurrences	2recurrences	NUM
gra-1903	4	25	.	.	PUNCT
gra-1903	5	1	cea	cea	PROPN
gra-1903	5	2	was	be	AUX
gra-1903	5	3	one	one	NUM
gra-1903	5	4	of	of	ADP
gra-1903	5	5	the	the	DET
gra-1903	5	6	rst	rst	PROPN
gra-1903	5	7	tumour	tumour	NOUN
gra-1903	5	8	markers	marker	NOUN
gra-1903	5	9	evaluated	evaluate	VERB
gra-1903	5	10	in	in	ADP
gra-1903	5	11	lung	lung	NOUN
gra-1903	5	12	cancer	cancer	NOUN
gra-1903	5	13	,	,	PUNCT
gra-1903	5	14	elevated	elevated	ADJ
gra-1903	5	15	levels	level	NOUN
gra-1903	5	16	are	be	AUX
gra-1903	5	17	seen	see	VERB
gra-1903	5	18	in	in	ADP
gra-1903	5	19	40–80	40–80	PROPN
gra-1903	5	20	%	%	NOUN
gra-1903	5	21	of	of	ADP
gra-1903	5	22	patients	patient	NOUN
gra-1903	5	23	with	with	ADP
gra-1903	5	24	lung	lung	NOUN
gra-1903	5	25	cancer	cancer	NOUN
gra-1903	5	26	.	.	PUNCT
gra-1903	6	1	cea	cea	PROPN
gra-1903	6	2	expression	expression	NOUN
gra-1903	6	3	and	and	CCONJ
gra-1903	6	4	secretion	secretion	NOUN
gra-1903	6	5	by	by	ADP
gra-1903	6	6	tumour	tumour	NOUN
gra-1903	6	7	cel	cel	PROPN
gra-1903	6	8	ls	ls	PROPN
gra-1903	6	9	promote	promote	NOUN
gra-1903	6	10	metastat	metastat	PROPN
gra-1903	6	11	ic	ic	PROPN
gra-1903	6	12	spread	spread	VERB
gra-1903	6	13	thereby	thereby	ADV
gra-1903	6	14	,	,	PUNCT
gra-1903	6	15	inammatory	inammatory	ADJ
gra-1903	6	16	environment	environment	NOUN
gra-1903	6	17	supporting	support	VERB
gra-1903	6	18	tumour	tumour	NOUN
gra-1903	6	19	formation	formation	NOUN
gra-1903	6	20	3helping	3helping	NUM
gra-1903	6	21	in	in	ADP
gra-1903	6	22	estimating	estimate	VERB
gra-1903	6	23	the	the	DET
gra-1903	6	24	prognosis	prognosis	NOUN
gra-1903	6	25	of	of	ADP
gra-1903	6	26	the	the	DET
gra-1903	6	27	disease	disease	NOUN
gra-1903	6	28	.	.	PUNCT
gra-1903	7	1	aims	aim	NOUN
gra-1903	7	2	&	&	CCONJ
gra-1903	7	3	objectives	objective	NOUN
gra-1903	7	4	ÿ	ÿ	X
gra-1903	7	5	to	to	PART
gra-1903	7	6	determine	determine	VERB
gra-1903	7	7	level	level	NOUN
gra-1903	7	8	of	of	ADP
gra-1903	7	9	cea	cea	PROPN
gra-1903	7	10	in	in	ADP
gra-1903	7	11	patients	patient	NOUN
gra-1903	7	12	with	with	ADP
gra-1903	7	13	biopsy	biopsy	NOUN
gra-1903	7	14	proven	prove	VERB
gra-1903	7	15	cases	case	NOUN
gra-1903	7	16	of	of	ADP
gra-1903	7	17	lung	lung	NOUN
gra-1903	7	18	cancer	cancer	NOUN
gra-1903	7	19	.	.	PUNCT
gra-1903	8	1	ÿ	ÿ	PRON
gra-1903	8	2	to	to	PART
gra-1903	8	3	evaluate	evaluate	VERB
gra-1903	8	4	serum	serum	PROPN
gra-1903	8	5	cea	cea	PROPN
gra-1903	8	6	levels	level	NOUN
gra-1903	8	7	as	as	ADP
gra-1903	8	8	a	a	DET
gra-1903	8	9	tumour	tumour	NOUN
gra-1903	8	10	marker	marker	NOUN
gra-1903	8	11	for	for	ADP
gra-1903	8	12	lung	lung	NOUN
gra-1903	8	13	cancer	cancer	NOUN
gra-1903	8	14	.	.	PUNCT
gra-1903	9	1	materials	material	NOUN
gra-1903	9	2	and	and	CCONJ
gra-1903	9	3	methods	method	NOUN
gra-1903	9	4	this	this	DET
gra-1903	9	5	study	study	NOUN
gra-1903	9	6	was	be	AUX
gra-1903	9	7	conducted	conduct	VERB
gra-1903	9	8	from	from	ADP
gra-1903	9	9	january	january	PROPN
gra-1903	9	10	2018	2018	NUM
gra-1903	9	11	to	to	ADP
gra-1903	9	12	october	october	PROPN
gra-1903	9	13	2019	2019	NUM
gra-1903	9	14	at	at	ADP
gra-1903	9	15	geetanjali	geetanjali	ADJ
gra-1903	9	16	hospital	hospital	NOUN
gra-1903	9	17	,	,	PUNCT
gra-1903	9	18	udaipur	udaipur	PROPN
gra-1903	9	19	.	.	PUNCT
gra-1903	10	1	study	study	NOUN
gra-1903	10	2	consisted	consist	VERB
gra-1903	10	3	of	of	ADP
gra-1903	10	4	74	74	NUM
gra-1903	10	5	patients	patient	NOUN
gra-1903	10	6	with	with	ADP
gra-1903	10	7	proven	prove	VERB
gra-1903	10	8	biopsy	biopsy	NOUN
gra-1903	10	9	of	of	ADP
gra-1903	10	10	carcinoma	carcinoma	NOUN
gra-1903	10	11	lung	lung	NOUN
gra-1903	10	12	and	and	CCONJ
gra-1903	10	13	demographic	demographic	ADJ
gra-1903	10	14	data	datum	NOUN
gra-1903	10	15	such	such	ADJ
gra-1903	10	16	as	as	ADP
gra-1903	10	17	age	age	NOUN
gra-1903	10	18	,	,	PUNCT
gra-1903	10	19	sex	sex	NOUN
gra-1903	10	20	&	&	CCONJ
gra-1903	10	21	addiction	addiction	NOUN
gra-1903	10	22	history	history	NOUN
gra-1903	10	23	were	be	AUX
gra-1903	10	24	noted	note	VERB
gra-1903	10	25	.	.	PUNCT
gra-1903	11	1	inclusion	inclusion	NOUN
gra-1903	11	2	criteria	criterion	NOUN
gra-1903	11	3	comprised	comprise	VERB
gra-1903	11	4	of	of	ADP
gra-1903	11	5	all	all	DET
gra-1903	11	6	male	male	ADJ
gra-1903	11	7	and	and	CCONJ
gra-1903	11	8	female	female	ADJ
gra-1903	11	9	patients	patient	NOUN
gra-1903	11	10	of	of	ADP
gra-1903	11	11	18	18	NUM
gra-1903	11	12	years	year	NOUN
gra-1903	11	13	and	and	CCONJ
gra-1903	11	14	above	above	ADV
gra-1903	11	15	,	,	PUNCT
gra-1903	11	16	histo	histo	NOUN
gra-1903	11	17	-	-	PUNCT
gra-1903	11	18	pathologically	pathologically	ADV
gra-1903	11	19	conrmed	conrme	VERB
gra-1903	11	20	cases	case	NOUN
gra-1903	11	21	of	of	ADP
gra-1903	11	22	carcinoma	carcinoma	NOUN
gra-1903	11	23	lung	lung	NOUN
gra-1903	11	24	and	and	CCONJ
gra-1903	11	25	patients	patient	NOUN
gra-1903	11	26	giving	give	VERB
gra-1903	11	27	informed	informed	ADJ
gra-1903	11	28	consent	consent	NOUN
gra-1903	11	29	.	.	PUNCT
gra-1903	12	1	exclusion	exclusion	NOUN
gra-1903	12	2	criteria	criterion	NOUN
gra-1903	12	3	included	include	VERB
gra-1903	12	4	all	all	DET
gra-1903	12	5	other	other	ADJ
gra-1903	12	6	malignancies	malignancy	NOUN
gra-1903	12	7	,	,	PUNCT
gra-1903	12	8	pancreatitis	pancreatitis	PROPN
gra-1903	12	9	,	,	PUNCT
gra-1903	12	10	inammatory	inammatory	ADJ
gra-1903	12	11	bowel	bowel	NOUN
gra-1903	12	12	disease	disease	NOUN
gra-1903	12	13	,	,	PUNCT
gra-1903	12	14	pancreatitis	pancreatitis	NOUN
gra-1903	12	15	,	,	PUNCT
gra-1903	12	16	cirrhosis	cirrhosis	NOUN
gra-1903	12	17	of	of	ADP
gra-1903	12	18	liver	liver	NOUN
gra-1903	12	19	.	.	PUNCT
gra-1903	13	1	the	the	DET
gra-1903	13	2	selected	select	VERB
gra-1903	13	3	patient	patient	ADJ
gra-1903	13	4	underwent	underwent	NOUN
gra-1903	13	5	serum	serum	NOUN
gra-1903	13	6	cea	cea	PROPN
gra-1903	13	7	level	level	NOUN
gra-1903	13	8	at	at	ADP
gra-1903	13	9	geetanjali	geetanjali	ADJ
gra-1903	13	10	medical	medical	ADJ
gra-1903	13	11	college	college	PROPN
gra-1903	13	12	and	and	CCONJ
gra-1903	13	13	hospital	hospital	NOUN
gra-1903	13	14	laboratory	laboratory	NOUN
gra-1903	13	15	with	with	ADP
gra-1903	13	16	the	the	DET
gra-1903	13	17	normal	normal	ADJ
gra-1903	13	18	reference	reference	NOUN
gra-1903	13	19	values	value	NOUN
gra-1903	13	20	as	as	ADP
gra-1903	13	21	per	per	ADP
gra-1903	13	22	gmch	gmch	ADJ
gra-1903	13	23	laboratory	laboratory	NOUN
gra-1903	13	24	protocols	protocol	NOUN
gra-1903	13	25	being	be	AUX
gra-1903	13	26	serum	serum	PROPN
gra-1903	13	27	cea	cea	PROPN
gra-1903	13	28	:	:	PUNCT
gra-1903	13	29	up	up	ADP
gra-1903	13	30	to	to	ADP
gra-1903	13	31	4ng	4ng	NOUN
gra-1903	13	32	/	/	SYM
gra-1903	13	33	ml	ml	NOUN
gra-1903	13	34	.	.	NOUN
gra-1903	13	35	results	result	NOUN
gra-1903	13	36	in	in	ADP
gra-1903	13	37	the	the	DET
gra-1903	13	38	present	present	ADJ
gra-1903	13	39	study	study	NOUN
gra-1903	13	40	,	,	PUNCT
gra-1903	13	41	maximum	maximum	ADJ
gra-1903	13	42	number	number	NOUN
gra-1903	13	43	of	of	ADP
gra-1903	13	44	patients	patient	NOUN
gra-1903	13	45	were	be	AUX
gra-1903	13	46	of	of	ADP
gra-1903	13	47	the	the	DET
gra-1903	13	48	age	age	NOUN
gra-1903	13	49	group	group	NOUN
gra-1903	13	50	between	between	ADP
gra-1903	13	51	51	51	NUM
gra-1903	13	52	to	to	PART
gra-1903	13	53	60	60	NUM
gra-1903	13	54	years	year	NOUN
gra-1903	13	55	(	(	PUNCT
gra-1903	13	56	41.89	41.89	NUM
gra-1903	13	57	%	%	NOUN
gra-1903	13	58	)	)	PUNCT
gra-1903	13	59	.68	.68	NUM
gra-1903	13	60	(	(	PUNCT
gra-1903	13	61	91.89	91.89	NUM
gra-1903	13	62	%	%	NOUN
gra-1903	13	63	)	)	PUNCT
gra-1903	13	64	males	male	NOUN
gra-1903	13	65	and	and	CCONJ
gra-1903	13	66	6	6	NUM
gra-1903	13	67	(	(	PUNCT
gra-1903	13	68	8.11	8.11	NUM
gra-1903	13	69	%	%	NOUN
gra-1903	13	70	)	)	PUNCT
gra-1903	13	71	female	female	ADJ
gra-1903	13	72	patients	patient	NOUN
gra-1903	13	73	were	be	AUX
gra-1903	13	74	affected	affect	VERB
gra-1903	13	75	.	.	PUNCT
gra-1903	14	1	maximum	maximum	ADJ
gra-1903	14	2	number	number	NOUN
gra-1903	14	3	of	of	ADP
gra-1903	14	4	patients	patient	NOUN
gra-1903	14	5	were	be	AUX
gra-1903	14	6	in	in	ADP
gra-1903	14	7	stage	stage	NOUN
gra-1903	14	8	iv	iv	NUM
gra-1903	14	9	accounting	account	VERB
gra-1903	14	10	for	for	ADP
gra-1903	14	11	42	42	NUM
gra-1903	14	12	(	(	PUNCT
gra-1903	14	13	56.76	56.76	NUM
gra-1903	14	14	%	%	NOUN
gra-1903	14	15	)	)	PUNCT
gra-1903	14	16	patients	patient	NOUN
gra-1903	14	17	.	.	PUNCT
gra-1903	15	1	38	38	NUM
gra-1903	15	2	(	(	PUNCT
gra-1903	15	3	51.35	51.35	NUM
gra-1903	15	4	%	%	NOUN
gra-1903	15	5	)	)	PUNCT
gra-1903	15	6	patients	patient	NOUN
gra-1903	15	7	were	be	AUX
gra-1903	15	8	of	of	ADP
gra-1903	15	9	adenocarcinoma	adenocarcinoma	NOUN
gra-1903	15	10	followed	follow	VERB
gra-1903	15	11	by	by	ADP
gra-1903	15	12	26	26	NUM
gra-1903	15	13	(	(	PUNCT
gra-1903	15	14	35.14	35.14	NUM
gra-1903	15	15	%	%	NOUN
gra-1903	15	16	)	)	PUNCT
gra-1903	15	17	with	with	ADP
gra-1903	15	18	squamous	squamous	ADJ
gra-1903	15	19	cell	cell	NOUN
gra-1903	15	20	carcinoma	carcinoma	NOUN
gra-1903	15	21	and	and	CCONJ
gra-1903	15	22	10	10	NUM
gra-1903	15	23	(	(	PUNCT
gra-1903	15	24	13.51	13.51	NUM
gra-1903	15	25	%	%	NOUN
gra-1903	15	26	)	)	PUNCT
gra-1903	15	27	with	with	ADP
gra-1903	15	28	small	small	ADJ
gra-1903	15	29	cell	cell	NOUN
gra-1903	15	30	carcinoma	carcinoma	NOUN
gra-1903	15	31	.	.	PUNCT
gra-1903	16	1	27	27	NUM
gra-1903	16	2	(	(	PUNCT
gra-1903	16	3	71.05	71.05	NUM
gra-1903	16	4	%	%	NOUN
gra-1903	16	5	)	)	PUNCT
gra-1903	16	6	out	out	ADP
gra-1903	16	7	of	of	ADP
gra-1903	16	8	38	38	NUM
gra-1903	16	9	patients	patient	NOUN
gra-1903	16	10	with	with	ADP
gra-1903	16	11	adenocarcinoma	adenocarcinoma	NOUN
gra-1903	16	12	,	,	PUNCT
gra-1903	16	13	10	10	NUM
gra-1903	16	14	(	(	PUNCT
gra-1903	16	15	38.48	38.48	NUM
gra-1903	16	16	%	%	NOUN
gra-1903	16	17	)	)	PUNCT
gra-1903	16	18	out	out	ADP
gra-1903	16	19	of	of	ADP
gra-1903	16	20	26	26	NUM
gra-1903	16	21	patients	patient	NOUN
gra-1903	16	22	with	with	ADP
gra-1903	16	23	squamous	squamous	ADJ
gra-1903	16	24	cell	cell	NOUN
gra-1903	16	25	carcinoma	carcinoma	NOUN
gra-1903	16	26	and	and	CCONJ
gra-1903	16	27	6	6	NUM
gra-1903	16	28	(	(	PUNCT
gra-1903	16	29	60	60	NUM
gra-1903	16	30	%	%	NOUN
gra-1903	16	31	)	)	PUNCT
gra-1903	16	32	out	out	ADP
gra-1903	16	33	of	of	ADP
gra-1903	16	34	10	10	NUM
gra-1903	16	35	patients	patient	NOUN
gra-1903	16	36	with	with	ADP
gra-1903	16	37	small	small	ADJ
gra-1903	16	38	cell	cell	NOUN
gra-1903	16	39	carcinoma	carcinoma	NOUN
gra-1903	16	40	showed	show	VERB
gra-1903	16	41	cea	cea	PROPN
gra-1903	16	42	values	value	NOUN
gra-1903	16	43	more	more	ADV
gra-1903	16	44	than	than	ADP
gra-1903	16	45	normal	normal	ADJ
gra-1903	16	46	.	.	PUNCT
gra-1903	17	1	on	on	ADP
gra-1903	17	2	applying	apply	VERB
gra-1903	17	3	chi	chi	PROPN
gra-1903	17	4	square	square	PROPN
gra-1903	17	5	test	test	NOUN
gra-1903	17	6	,	,	PUNCT
gra-1903	17	7	the	the	DET
gra-1903	17	8	difference	difference	NOUN
gra-1903	17	9	was	be	AUX
gra-1903	17	10	found	find	VERB
gra-1903	17	11	statistically	statistically	ADV
gra-1903	17	12	signicant	signicant	ADJ
gra-1903	17	13	with	with	ADP
gra-1903	17	14	p	p	NOUN
gra-1903	17	15	value	value	NOUN
gra-1903	17	16	of	of	ADP
gra-1903	17	17	(	(	PUNCT
gra-1903	17	18	.034	.034	NUM
gra-1903	17	19	)	)	PUNCT
gra-1903	17	20	.	.	PUNCT
gra-1903	18	1	30	30	NUM
gra-1903	18	2	(	(	PUNCT
gra-1903	18	3	71.43	71.43	NUM
gra-1903	18	4	%	%	NOUN
gra-1903	18	5	)	)	PUNCT
gra-1903	18	6	patients	patient	NOUN
gra-1903	18	7	out	out	ADP
gra-1903	18	8	of	of	ADP
gra-1903	18	9	42	42	NUM
gra-1903	18	10	of	of	ADP
gra-1903	18	11	stage	stage	NOUN
gra-1903	18	12	iv	iv	X
gra-1903	18	13	,	,	PUNCT
gra-1903	18	14	all	all	DET
gra-1903	18	15	5	5	NUM
gra-1903	18	16	patients	patient	NOUN
gra-1903	18	17	of	of	ADP
gra-1903	18	18	stage	stage	NOUN
gra-1903	18	19	iiib,4(57.14	iiib,4(57.14	PROPN
gra-1903	18	20	%	%	NOUN
gra-1903	18	21	)	)	PUNCT
gra-1903	18	22	out	out	ADP
gra-1903	18	23	of	of	ADP
gra-1903	18	24	7	7	NUM
gra-1903	18	25	cases	case	NOUN
gra-1903	18	26	of	of	ADP
gra-1903	18	27	iiia	iiia	NOUN
gra-1903	18	28	and	and	CCONJ
gra-1903	18	29	2	2	NUM
gra-1903	18	30	(	(	PUNCT
gra-1903	18	31	28.57	28.57	NUM
gra-1903	18	32	%	%	NOUN
gra-1903	18	33	)	)	PUNCT
gra-1903	18	34	out	out	ADP
gra-1903	18	35	of	of	ADP
gra-1903	18	36	7	7	NUM
gra-1903	18	37	cases	case	NOUN
gra-1903	18	38	of	of	ADP
gra-1903	18	39	both	both	DET
gra-1903	18	40	stages	stage	NOUN
gra-1903	18	41	iia	iia	PROPN
gra-1903	18	42	&	&	CCONJ
gra-1903	18	43	iib	iib	PROPN
gra-1903	18	44	showed	show	VERB
gra-1903	18	45	higher	high	ADJ
gra-1903	18	46	cea	cea	PROPN
gra-1903	18	47	level	level	NOUN
gra-1903	18	48	than	than	ADP
gra-1903	18	49	normal	normal	ADJ
gra-1903	18	50	.	.	PUNCT
gra-1903	19	1	on	on	ADP
gra-1903	19	2	applying	apply	VERB
gra-1903	19	3	chi	chi	PROPN
gra-1903	19	4	square	square	PROPN
gra-1903	19	5	test	test	NOUN
gra-1903	19	6	,	,	PUNCT
gra-1903	19	7	the	the	DET
gra-1903	19	8	difference	difference	NOUN
gra-1903	19	9	was	be	AUX
gra-1903	19	10	found	find	VERB
gra-1903	19	11	statistically	statistically	ADV
gra-1903	19	12	signicant	signicant	ADJ
gra-1903	19	13	with	with	ADP
gra-1903	19	14	p	p	NOUN
gra-1903	19	15	value	value	NOUN
gra-1903	19	16	of	of	ADP
gra-1903	19	17	(	(	PUNCT
gra-1903	19	18	.005	.005	NUM
gra-1903	19	19	)	)	PUNCT
gra-1903	19	20	.	.	PUNCT
gra-1903	20	1	42	42	NUM
gra-1903	20	2	out	out	ADP
gra-1903	20	3	of	of	ADP
gra-1903	20	4	74	74	NUM
gra-1903	20	5	patients	patient	NOUN
gra-1903	20	6	developed	develop	VERB
gra-1903	20	7	metastasis	metastasis	NOUN
gra-1903	20	8	wherein	wherein	SCONJ
gra-1903	20	9	highest	high	ADJ
gra-1903	20	10	number	number	NOUN
gra-1903	20	11	of	of	ADP
gra-1903	20	12	cases	case	NOUN
gra-1903	20	13	were	be	AUX
gra-1903	20	14	seen	see	VERB
gra-1903	20	15	with	with	ADP
gra-1903	20	16	adenocarcinoma	adenocarcinoma	NOUN
gra-1903	20	17	being	be	AUX
gra-1903	20	18	24	24	NUM
gra-1903	20	19	patients	patient	NOUN
gra-1903	20	20	and	and	CCONJ
gra-1903	20	21	highest	high	ADJ
gra-1903	20	22	frequency	frequency	NOUN
gra-1903	20	23	of	of	ADP
gra-1903	20	24	metastasis	metastasis	NOUN
gra-1903	20	25	was	be	AUX
gra-1903	20	26	seen	see	VERB
gra-1903	20	27	to	to	PART
gra-1903	20	28	adrenals	adrenal	NOUN
gra-1903	20	29	in	in	ADP
gra-1903	20	30	10	10	NUM
gra-1903	20	31	patients	patient	NOUN
gra-1903	20	32	.	.	PUNCT
gra-1903	21	1	higher	high	ADJ
gra-1903	21	2	than	than	ADP
gra-1903	21	3	normal	normal	ADJ
gra-1903	21	4	level	level	NOUN
gra-1903	21	5	of	of	ADP
gra-1903	21	6	cea	cea	PROPN
gra-1903	21	7	was	be	AUX
gra-1903	21	8	seen	see	VERB
gra-1903	21	9	in	in	ADP
gra-1903	21	10	all	all	DET
gra-1903	21	11	3	3	NUM
gra-1903	21	12	(	(	PUNCT
gra-1903	21	13	100	100	NUM
gra-1903	21	14	%	%	NOUN
gra-1903	21	15	)	)	PUNCT
gra-1903	21	16	patients	patient	NOUN
gra-1903	21	17	of	of	ADP
gra-1903	21	18	pleural	pleural	ADJ
gra-1903	21	19	metastasis	metastasis	NOUN
gra-1903	21	20	followed	follow	VERB
gra-1903	21	21	by	by	ADP
gra-1903	21	22	brain	brain	NOUN
gra-1903	21	23	metastasis	metastasis	NOUN
gra-1903	21	24	was	be	AUX
gra-1903	21	25	seen	see	VERB
gra-1903	21	26	in	in	ADP
gra-1903	21	27	5	5	NUM
gra-1903	21	28	(	(	PUNCT
gra-1903	21	29	83.33	83.33	NUM
gra-1903	21	30	%	%	NOUN
gra-1903	21	31	)	)	PUNCT
gra-1903	21	32	patients	patient	NOUN
gra-1903	21	33	out	out	ADP
gra-1903	21	34	of	of	ADP
gra-1903	21	35	6	6	NUM
gra-1903	21	36	patients	patient	NOUN
gra-1903	21	37	,	,	PUNCT
gra-1903	21	38	liver	liver	NOUN
gra-1903	21	39	metastasis	metastasis	NOUN
gra-1903	21	40	was	be	AUX
gra-1903	21	41	seen	see	VERB
gra-1903	21	42	in	in	ADP
gra-1903	21	43	5	5	NUM
gra-1903	21	44	(	(	PUNCT
gra-1903	21	45	71.43	71.43	NUM
gra-1903	21	46	%	%	NOUN
gra-1903	21	47	)	)	PUNCT
gra-1903	21	48	patients	patient	NOUN
gra-1903	21	49	out	out	ADP
gra-1903	21	50	of	of	ADP
gra-1903	21	51	7	7	NUM
gra-1903	21	52	patients	patient	NOUN
gra-1903	21	53	,	,	PUNCT
gra-1903	21	54	adrenal	adrenal	ADJ
gra-1903	21	55	metastasis	metastasis	NOUN
gra-1903	21	56	was	be	AUX
gra-1903	21	57	seen	see	VERB
gra-1903	21	58	in	in	ADP
gra-1903	21	59	6	6	NUM
gra-1903	21	60	(	(	PUNCT
gra-1903	21	61	60	60	NUM
gra-1903	21	62	%	%	NOUN
gra-1903	21	63	)	)	PUNCT
gra-1903	21	64	patients	patient	NOUN
gra-1903	21	65	out	out	ADP
gra-1903	21	66	of	of	ADP
gra-1903	21	67	10	10	NUM
gra-1903	21	68	patients	patient	NOUN
gra-1903	21	69	,	,	PUNCT
gra-1903	21	70	bone	bone	NOUN
gra-1903	21	71	metastasis	metastasis	NOUN
gra-1903	21	72	was	be	AUX
gra-1903	21	73	seen	see	VERB
gra-1903	21	74	in	in	ADP
gra-1903	21	75	4	4	NUM
gra-1903	21	76	(	(	PUNCT
gra-1903	21	77	57.14	57.14	NUM
gra-1903	21	78	%	%	NOUN
gra-1903	21	79	)	)	PUNCT
gra-1903	21	80	patients	patient	NOUN
gra-1903	21	81	out	out	ADP
gra-1903	21	82	of	of	ADP
gra-1903	21	83	7	7	NUM
gra-1903	21	84	,	,	PUNCT
gra-1903	21	85	7	7	NUM
gra-1903	21	86	(	(	PUNCT
gra-1903	21	87	77.78	77.78	NUM
gra-1903	21	88	%	%	NOUN
gra-1903	21	89	)	)	PUNCT
gra-1903	21	90	patients	patient	NOUN
gra-1903	21	91	out	out	ADP
gra-1903	21	92	of	of	ADP
gra-1903	21	93	9	9	NUM
gra-1903	21	94	patients	patient	NOUN
gra-1903	21	95	of	of	ADP
gra-1903	21	96	multiple	multiple	ADJ
gra-1903	21	97	metastasis	metastasis	NOUN
gra-1903	21	98	showed	show	VERB
gra-1903	21	99	higher	high	ADJ
gra-1903	21	100	than	than	ADP
gra-1903	21	101	normal	normal	ADJ
gra-1903	21	102	level	level	NOUN
gra-1903	21	103	of	of	ADP
gra-1903	21	104	cea	cea	PROPN
gra-1903	21	105	.	.	PUNCT
gra-1903	22	1	on	on	ADP
gra-1903	22	2	applying	apply	VERB
gra-1903	22	3	chi	chi	PROPN
gra-1903	22	4	square	square	PROPN
gra-1903	22	5	test	test	NOUN
gra-1903	22	6	,	,	PUNCT
gra-1903	22	7	the	the	DET
gra-1903	22	8	difference	difference	NOUN
gra-1903	22	9	was	be	AUX
gra-1903	22	10	found	find	VERB
gra-1903	22	11	statistically	statistically	ADV
gra-1903	22	12	non	non	ADJ
gra-1903	22	13	-	-	ADJ
gra-1903	22	14	signicant	signicant	ADJ
gra-1903	22	15	with	with	ADP
gra-1903	22	16	p	p	NOUN
gra-1903	22	17	value	value	NOUN
gra-1903	22	18	of	of	ADP
gra-1903	22	19	(	(	PUNCT
gra-1903	22	20	0.679	0.679	NUM
gra-1903	22	21	)	)	PUNCT
gra-1903	22	22	.	.	PUNCT
gra-1903	23	1	table	table	NOUN
gra-1903	23	2	1	1	NUM
gra-1903	23	3	types	type	NOUN
gra-1903	23	4	of	of	ADP
gra-1903	23	5	distribution	distribution	NOUN
gra-1903	23	6	a	a	DET
gra-1903	23	7	study	study	NOUN
gra-1903	23	8	of	of	ADP
gra-1903	23	9	carcino	carcino	PROPN
gra-1903	23	10	embryonic	embryonic	ADJ
gra-1903	23	11	antigen	antigen	NOUN
gra-1903	23	12	(	(	PUNCT
gra-1903	23	13	cea	cea	PROPN
gra-1903	23	14	)	)	PUNCT
gra-1903	23	15	levels	level	NOUN
gra-1903	23	16	in	in	ADP
gra-1903	23	17	lung	lung	NOUN
gra-1903	23	18	cancer	cancer	NOUN
gra-1903	23	19	original	original	ADJ
gra-1903	23	20	research	research	NOUN
gra-1903	23	21	paper	paper	NOUN
gra-1903	23	22	dave	dave	PROPN
gra-1903	23	23	manan	manan	PROPN
gra-1903	23	24	resident	resident	PROPN
gra-1903	23	25	,	,	PUNCT
gra-1903	23	26	department	department	NOUN
gra-1903	23	27	of	of	ADP
gra-1903	23	28	general	general	ADJ
gra-1903	23	29	medicine	medicine	NOUN
gra-1903	23	30	,	,	PUNCT
gra-1903	23	31	geetanjali	geetanjali	VERB
gra-1903	23	32	medical	medical	ADJ
gra-1903	23	33	college	college	PROPN
gra-1903	23	34	and	and	CCONJ
gra-1903	23	35	hospital	hospital	NOUN
gra-1903	23	36	,	,	PUNCT
gra-1903	23	37	udaipur	udaipur	PROPN
gra-1903	23	38	,	,	PUNCT
gra-1903	23	39	rajasthan	rajasthan	PROPN
gra-1903	23	40	,	,	PUNCT
gra-1903	23	41	india	india	PROPN
gra-1903	23	42	x	x	SYM
gra-1903	24	1	59gjra	59gjra	PROPN
gra-1903	24	2	global	global	ADJ
gra-1903	24	3	journal	journal	PROPN
gra-1903	24	4	for	for	ADP
gra-1903	24	5	research	research	NOUN
gra-1903	24	6	analysis	analysis	NOUN
gra-1903	24	7	general	general	ADJ
gra-1903	24	8	medicine	medicine	NOUN
gra-1903	24	9	background	background	NOUN
gra-1903	24	10	lung	lung	NOUN
gra-1903	24	11	cancer	cancer	NOUN
gra-1903	24	12	is	be	AUX
gra-1903	24	13	a	a	DET
gra-1903	24	14	major	major	ADJ
gra-1903	24	15	cause	cause	NOUN
gra-1903	24	16	of	of	ADP
gra-1903	24	17	cancer	cancer	NOUN
gra-1903	24	18	-	-	PUNCT
gra-1903	24	19	related	relate	VERB
gra-1903	24	20	mortality	mortality	NOUN
gra-1903	24	21	.	.	PUNCT
gra-1903	25	1	about	about	ADV
gra-1903	25	2	85	85	NUM
gra-1903	25	3	%	%	NOUN
gra-1903	25	4	of	of	ADP
gra-1903	25	5	cases	case	NOUN
gra-1903	25	6	are	be	AUX
gra-1903	25	7	related	relate	VERB
gra-1903	25	8	to	to	ADP
gra-1903	25	9	cigarette	cigarette	NOUN
gra-1903	25	10	smoking	smoking	NOUN
gra-1903	25	11	.	.	PUNCT
gra-1903	26	1	cea	cea	PROPN
gra-1903	26	2	was	be	AUX
gra-1903	26	3	one	one	NUM
gra-1903	26	4	of	of	ADP
gra-1903	26	5	the	the	DET
gra-1903	26	6	tumour	tumour	NOUN
gra-1903	26	7	markers	marker	NOUN
gra-1903	26	8	use	use	VERB
gra-1903	26	9	to	to	PART
gra-1903	26	10	evaluate	evaluate	VERB
gra-1903	26	11	lung	lung	NOUN
gra-1903	26	12	cancer	cancer	NOUN
gra-1903	26	13	,	,	PUNCT
gra-1903	26	14	also	also	ADV
gra-1903	26	15	elevated	elevated	ADJ
gra-1903	26	16	levels	level	NOUN
gra-1903	26	17	are	be	AUX
gra-1903	26	18	seen	see	VERB
gra-1903	26	19	in	in	ADP
gra-1903	26	20	40–80	40–80	PROPN
gra-1903	26	21	%	%	NOUN
gra-1903	26	22	of	of	ADP
gra-1903	26	23	patients	patient	NOUN
gra-1903	26	24	with	with	ADP
gra-1903	26	25	lung	lung	NOUN
gra-1903	26	26	cancer	cancer	NOUN
gra-1903	26	27	,	,	PUNCT
gra-1903	26	28	showing	show	VERB
gra-1903	26	29	a	a	DET
gra-1903	26	30	high	high	ADJ
gra-1903	26	31	sensitivity	sensitivity	NOUN
gra-1903	26	32	for	for	ADP
gra-1903	26	33	adenocarcinoma	adenocarcinoma	NOUN
gra-1903	26	34	and	and	CCONJ
gra-1903	26	35	for	for	ADP
gra-1903	26	36	advanced	advanced	ADJ
gra-1903	26	37	stage	stage	NOUN
gra-1903	26	38	studies	study	NOUN
gra-1903	26	39	show	show	VERB
gra-1903	26	40	that	that	SCONJ
gra-1903	26	41	cea	cea	PROPN
gra-1903	26	42	level	level	NOUN
gra-1903	26	43	in	in	ADP
gra-1903	26	44	serum	serum	NOUN
gra-1903	26	45	is	be	AUX
gra-1903	26	46	signicantly	signicantly	ADV
gra-1903	26	47	increasing	increase	VERB
gra-1903	26	48	in	in	ADP
gra-1903	26	49	patients	patient	NOUN
gra-1903	26	50	with	with	ADP
gra-1903	26	51	lung	lung	NOUN
gra-1903	26	52	cancer	cancer	NOUN
gra-1903	26	53	.	.	PUNCT
gra-1903	27	1	serum	serum	PROPN
gra-1903	27	2	cea	cea	PROPN
gra-1903	27	3	level	level	NOUN
gra-1903	27	4	can	can	AUX
gra-1903	27	5	be	be	AUX
gra-1903	27	6	used	use	VERB
gra-1903	27	7	as	as	ADP
gra-1903	27	8	a	a	DET
gra-1903	27	9	sensitive	sensitive	ADJ
gra-1903	27	10	and	and	CCONJ
gra-1903	27	11	specic	specic	NOUN
gra-1903	27	12	screening	screen	VERB
gra-1903	27	13	test	test	NOUN
gra-1903	27	14	for	for	ADP
gra-1903	27	15	various	various	ADJ
gra-1903	27	16	cancers	cancer	NOUN
gra-1903	27	17	including	include	VERB
gra-1903	27	18	lung	lung	NOUN
gra-1903	27	19	cancer	cancer	NOUN
gra-1903	27	20	.	.	PUNCT
gra-1903	28	1	method	method	NOUN
gra-1903	28	2	74	74	NUM
gra-1903	28	3	patients	patient	NOUN
gra-1903	28	4	were	be	AUX
gra-1903	28	5	studied	study	VERB
gra-1903	28	6	at	at	ADP
gra-1903	28	7	geetanjali	geetanjali	ADJ
gra-1903	28	8	hospital	hospital	NOUN
gra-1903	28	9	,	,	PUNCT
gra-1903	28	10	udaipur	udaipur	NOUN
gra-1903	28	11	.	.	PUNCT
gra-1903	29	1	only	only	ADV
gra-1903	29	2	biopsy	biopsy	VERB
gra-1903	29	3	proven	prove	VERB
gra-1903	29	4	cases	case	NOUN
gra-1903	29	5	of	of	ADP
gra-1903	29	6	carcinoma	carcinoma	NOUN
gra-1903	29	7	lung	lung	NOUN
gra-1903	29	8	were	be	AUX
gra-1903	29	9	interviewed	interview	VERB
gra-1903	29	10	and	and	CCONJ
gra-1903	29	11	demographic	demographic	ADJ
gra-1903	29	12	data	datum	NOUN
gra-1903	29	13	such	such	ADJ
gra-1903	29	14	as	as	ADP
gra-1903	29	15	age	age	NOUN
gra-1903	29	16	,	,	PUNCT
gra-1903	29	17	sex	sex	NOUN
gra-1903	29	18	&	&	CCONJ
gra-1903	29	19	addiction	addiction	NOUN
gra-1903	29	20	history	history	NOUN
gra-1903	29	21	were	be	AUX
gra-1903	29	22	noted	note	VERB
gra-1903	29	23	.	.	PUNCT
gra-1903	30	1	results	result	NOUN
gra-1903	30	2	among	among	ADP
gra-1903	30	3	74	74	NUM
gra-1903	30	4	patients	patient	NOUN
gra-1903	30	5	diagnosed	diagnose	VERB
gra-1903	30	6	with	with	ADP
gra-1903	30	7	lung	lung	NOUN
gra-1903	30	8	cancer	cancer	NOUN
gra-1903	30	9	highest	high	ADJ
gra-1903	30	10	cases	case	NOUN
gra-1903	30	11	were	be	AUX
gra-1903	30	12	seen	see	VERB
gra-1903	30	13	in	in	ADP
gra-1903	30	14	patients	patient	NOUN
gra-1903	30	15	with	with	ADP
gra-1903	30	16	adenocarcinoma	adenocarcinoma	NOUN
gra-1903	30	17	38	38	NUM
gra-1903	30	18	(	(	PUNCT
gra-1903	30	19	51.35	51.35	NUM
gra-1903	30	20	%	%	NOUN
gra-1903	30	21	)	)	PUNCT
gra-1903	30	22	followed	follow	VERB
gra-1903	30	23	by	by	ADP
gra-1903	30	24	squamous	squamous	ADJ
gra-1903	30	25	cell	cell	NOUN
gra-1903	30	26	carcinoma	carcinoma	NOUN
gra-1903	30	27	with	with	ADP
gra-1903	30	28	26	26	NUM
gra-1903	30	29	(	(	PUNCT
gra-1903	30	30	35.14	35.14	NUM
gra-1903	30	31	%	%	NOUN
gra-1903	30	32	)	)	PUNCT
gra-1903	30	33	followed	follow	VERB
gra-1903	30	34	by	by	ADP
gra-1903	30	35	small	small	ADJ
gra-1903	30	36	cell	cell	NOUN
gra-1903	30	37	carcinoma	carcinoma	NOUN
gra-1903	30	38	10	10	NUM
gra-1903	30	39	(	(	PUNCT
gra-1903	30	40	13.51	13.51	NUM
gra-1903	30	41	%	%	NOUN
gra-1903	30	42	)	)	PUNCT
gra-1903	30	43	.	.	PUNCT
gra-1903	31	1	27	27	NUM
gra-1903	31	2	(	(	PUNCT
gra-1903	31	3	71.05	71.05	NUM
gra-1903	31	4	%	%	NOUN
gra-1903	31	5	)	)	PUNCT
gra-1903	31	6	out	out	ADP
gra-1903	31	7	of	of	ADP
gra-1903	31	8	38	38	NUM
gra-1903	31	9	patients	patient	NOUN
gra-1903	31	10	of	of	ADP
gra-1903	31	11	adenocarcinoma	adenocarcinoma	NOUN
gra-1903	31	12	,	,	PUNCT
gra-1903	31	13	10	10	NUM
gra-1903	31	14	(	(	PUNCT
gra-1903	31	15	38.48	38.48	NUM
gra-1903	31	16	%	%	NOUN
gra-1903	31	17	)	)	PUNCT
gra-1903	31	18	out	out	ADP
gra-1903	31	19	of	of	ADP
gra-1903	31	20	26	26	NUM
gra-1903	31	21	patients	patient	NOUN
gra-1903	31	22	of	of	ADP
gra-1903	31	23	squamous	squamous	ADJ
gra-1903	31	24	cell	cell	NOUN
gra-1903	31	25	carcinoma	carcinoma	NOUN
gra-1903	31	26	and	and	CCONJ
gra-1903	31	27	6	6	NUM
gra-1903	31	28	(	(	PUNCT
gra-1903	31	29	60	60	NUM
gra-1903	31	30	%	%	NOUN
gra-1903	31	31	)	)	PUNCT
gra-1903	31	32	out	out	ADP
gra-1903	31	33	of	of	ADP
gra-1903	31	34	10	10	NUM
gra-1903	31	35	patients	patient	NOUN
gra-1903	31	36	of	of	ADP
gra-1903	31	37	small	small	ADJ
gra-1903	31	38	cell	cell	NOUN
gra-1903	31	39	carcinoma	carcinoma	NOUN
gra-1903	31	40	showed	show	VERB
gra-1903	31	41	cea	cea	PROPN
gra-1903	31	42	values	value	NOUN
gra-1903	31	43	more	more	ADV
gra-1903	31	44	than	than	ADP
gra-1903	31	45	normal	normal	ADJ
gra-1903	31	46	.	.	PUNCT
gra-1903	32	1	30	30	NUM
gra-1903	32	2	(	(	PUNCT
gra-1903	32	3	71.43	71.43	NUM
gra-1903	32	4	%	%	NOUN
gra-1903	32	5	)	)	PUNCT
gra-1903	32	6	patients	patient	NOUN
gra-1903	32	7	out	out	ADP
gra-1903	32	8	of	of	ADP
gra-1903	32	9	42	42	NUM
gra-1903	32	10	of	of	ADP
gra-1903	32	11	stage	stage	NOUN
gra-1903	32	12	iv	iv	X
gra-1903	32	13	,	,	PUNCT
gra-1903	32	14	all	all	DET
gra-1903	32	15	5	5	NUM
gra-1903	32	16	patients	patient	NOUN
gra-1903	32	17	of	of	ADP
gra-1903	32	18	stage	stage	NOUN
gra-1903	32	19	iiib	iiib	NOUN
gra-1903	32	20	4	4	NUM
gra-1903	32	21	(	(	PUNCT
gra-1903	32	22	57.14	57.14	NUM
gra-1903	32	23	%	%	NOUN
gra-1903	32	24	)	)	PUNCT
gra-1903	32	25	out	out	ADP
gra-1903	32	26	of	of	ADP
gra-1903	32	27	7	7	NUM
gra-1903	32	28	of	of	ADP
gra-1903	32	29	iiia	iiia	VERB
gra-1903	32	30	patients	patient	NOUN
gra-1903	32	31	2	2	NUM
gra-1903	32	32	(	(	PUNCT
gra-1903	32	33	28.57	28.57	NUM
gra-1903	32	34	%	%	NOUN
gra-1903	32	35	)	)	PUNCT
gra-1903	32	36	out	out	ADP
gra-1903	32	37	of	of	ADP
gra-1903	32	38	7	7	NUM
gra-1903	32	39	patients	patient	NOUN
gra-1903	32	40	of	of	ADP
gra-1903	32	41	both	both	DET
gra-1903	32	42	stages	stage	NOUN
gra-1903	32	43	iia	iia	PROPN
gra-1903	32	44	&	&	CCONJ
gra-1903	32	45	iib	iib	PROPN
gra-1903	32	46	showed	show	VERB
gra-1903	32	47	higher	high	ADJ
gra-1903	32	48	cea	cea	PROPN
gra-1903	32	49	level	level	NOUN
gra-1903	32	50	than	than	ADP
gra-1903	32	51	normal	normal	ADJ
gra-1903	32	52	.	.	PUNCT
gra-1903	33	1	higher	high	ADJ
gra-1903	33	2	than	than	ADP
gra-1903	33	3	normal	normal	ADJ
gra-1903	33	4	level	level	NOUN
gra-1903	33	5	of	of	ADP
gra-1903	33	6	cea	cea	PROPN
gra-1903	33	7	was	be	AUX
gra-1903	33	8	seen	see	VERB
gra-1903	33	9	in	in	ADP
gra-1903	33	10	all	all	DET
gra-1903	33	11	3	3	NUM
gra-1903	33	12	(	(	PUNCT
gra-1903	33	13	100	100	NUM
gra-1903	33	14	%	%	NOUN
gra-1903	33	15	)	)	PUNCT
gra-1903	33	16	patients	patient	NOUN
gra-1903	33	17	of	of	ADP
gra-1903	33	18	pleural	pleural	ADJ
gra-1903	33	19	metastasis	metastasis	NOUN
gra-1903	33	20	followed	follow	VERB
gra-1903	33	21	by	by	ADP
gra-1903	33	22	brain	brain	NOUN
gra-1903	33	23	metastasis	metastasis	NOUN
gra-1903	33	24	was	be	AUX
gra-1903	33	25	seen	see	VERB
gra-1903	33	26	in	in	ADP
gra-1903	33	27	5	5	NUM
gra-1903	33	28	(	(	PUNCT
gra-1903	33	29	83.33	83.33	NUM
gra-1903	33	30	%	%	NOUN
gra-1903	33	31	)	)	PUNCT
gra-1903	33	32	out	out	ADP
gra-1903	33	33	of	of	ADP
gra-1903	33	34	6	6	NUM
gra-1903	33	35	patients	patient	NOUN
gra-1903	33	36	,	,	PUNCT
gra-1903	33	37	liver	liver	NOUN
gra-1903	33	38	metastasis	metastasis	NOUN
gra-1903	33	39	was	be	AUX
gra-1903	33	40	seen	see	VERB
gra-1903	33	41	in	in	ADP
gra-1903	33	42	5	5	NUM
gra-1903	33	43	(	(	PUNCT
gra-1903	33	44	71.43	71.43	NUM
gra-1903	33	45	%	%	NOUN
gra-1903	33	46	)	)	PUNCT
gra-1903	33	47	out	out	ADP
gra-1903	33	48	of	of	ADP
gra-1903	33	49	7	7	NUM
gra-1903	33	50	patients	patient	NOUN
gra-1903	33	51	,	,	PUNCT
gra-1903	33	52	adrenal	adrenal	ADJ
gra-1903	33	53	metastasis	metastasis	NOUN
gra-1903	33	54	was	be	AUX
gra-1903	33	55	seen	see	VERB
gra-1903	33	56	in	in	ADP
gra-1903	33	57	6	6	NUM
gra-1903	33	58	(	(	PUNCT
gra-1903	33	59	60	60	NUM
gra-1903	33	60	%	%	NOUN
gra-1903	33	61	)	)	PUNCT
gra-1903	33	62	out	out	ADP
gra-1903	33	63	of	of	ADP
gra-1903	33	64	10	10	NUM
gra-1903	33	65	patients	patient	NOUN
gra-1903	33	66	,	,	PUNCT
gra-1903	33	67	bone	bone	NOUN
gra-1903	33	68	metastasis	metastasis	NOUN
gra-1903	33	69	was	be	AUX
gra-1903	33	70	seen	see	VERB
gra-1903	33	71	in	in	ADP
gra-1903	33	72	4	4	NUM
gra-1903	33	73	(	(	PUNCT
gra-1903	33	74	57.14	57.14	NUM
gra-1903	33	75	%	%	NOUN
gra-1903	33	76	)	)	PUNCT
gra-1903	33	77	out	out	ADP
gra-1903	33	78	of	of	ADP
gra-1903	33	79	7	7	NUM
gra-1903	33	80	patients	patient	NOUN
gra-1903	33	81	showed	show	VERB
gra-1903	33	82	higher	high	ADJ
gra-1903	33	83	than	than	ADP
gra-1903	33	84	normal	normal	ADJ
gra-1903	33	85	level	level	NOUN
gra-1903	33	86	of	of	ADP
gra-1903	33	87	cea	cea	PROPN
gra-1903	33	88	.	.	PUNCT
gra-1903	34	1	conclusion	conclusion	NOUN
gra-1903	34	2	this	this	DET
gra-1903	34	3	observation	observation	NOUN
gra-1903	34	4	highlights	highlight	VERB
gra-1903	34	5	the	the	DET
gra-1903	34	6	importance	importance	NOUN
gra-1903	34	7	of	of	ADP
gra-1903	34	8	tumour	tumour	NOUN
gra-1903	34	9	markers	marker	NOUN
gra-1903	34	10	in	in	ADP
gra-1903	34	11	relation	relation	NOUN
gra-1903	34	12	to	to	ADP
gra-1903	34	13	histological	histological	ADJ
gra-1903	34	14	type	type	NOUN
gra-1903	34	15	and	and	CCONJ
gra-1903	34	16	tumour	tumour	NOUN
gra-1903	34	17	staging	staging	NOUN
gra-1903	34	18	.	.	PUNCT
gra-1903	35	1	routine	routine	ADJ
gra-1903	35	2	serum	serum	PROPN
gra-1903	35	3	cea	cea	PROPN
gra-1903	35	4	testing	testing	NOUN
gra-1903	35	5	in	in	ADP
gra-1903	35	6	patients	patient	NOUN
gra-1903	35	7	with	with	ADP
gra-1903	35	8	nonsmall	nonsmall	NOUN
gra-1903	35	9	cell	cell	NOUN
gra-1903	35	10	lung	lung	NOUN
gra-1903	35	11	carcinoma	carcinoma	NOUN
gra-1903	35	12	than	than	ADP
gra-1903	35	13	small	small	ADJ
gra-1903	35	14	cell	cell	NOUN
gra-1903	35	15	lung	lung	NOUN
gra-1903	35	16	carcinoma	carcinoma	NOUN
gra-1903	35	17	,	,	PUNCT
gra-1903	35	18	allows	allow	VERB
gra-1903	35	19	the	the	DET
gra-1903	35	20	identication	identication	NOUN
gra-1903	35	21	of	of	ADP
gra-1903	35	22	a	a	DET
gra-1903	35	23	signicant	signicant	ADJ
gra-1903	35	24	proportion	proportion	NOUN
gra-1903	35	25	of	of	ADP
gra-1903	35	26	patients	patient	NOUN
gra-1903	35	27	at	at	ADP
gra-1903	35	28	high	high	ADJ
gra-1903	35	29	risk	risk	NOUN
gra-1903	35	30	of	of	ADP
gra-1903	35	31	developing	develop	VERB
gra-1903	35	32	a	a	DET
gra-1903	35	33	tumour	tumour	NOUN
gra-1903	35	34	relapse	relapse	NOUN
gra-1903	35	35	being	be	AUX
gra-1903	35	36	cost	cost	NOUN
gra-1903	35	37	effective	effective	ADJ
gra-1903	35	38	.	.	PUNCT
gra-1903	36	1	abstract	abstract	ADJ
gra-1903	36	2	keywords	keyword	NOUN
gra-1903	36	3	:	:	PUNCT
gra-1903	36	4	lung	lung	NOUN
gra-1903	36	5	cancer	cancer	NOUN
gra-1903	36	6	,	,	PUNCT
gra-1903	36	7	carcinoembryonic	carcinoembryonic	ADJ
gra-1903	36	8	antigen	antigen	NOUN
gra-1903	36	9	levels	level	NOUN
gra-1903	36	10	volume-9	volume-9	NUM
gra-1903	36	11	,	,	PUNCT
gra-1903	36	12	issue-2	issue-2	PROPN
gra-1903	36	13	,	,	PUNCT
gra-1903	36	14	february-2020	february-2020	VERB
gra-1903	36	15	•	•	NUM
gra-1903	36	16	print	print	NOUN
gra-1903	36	17	issn	issn	PROPN
gra-1903	36	18	no	no	NOUN
gra-1903	36	19	.	.	PROPN
gra-1903	36	20	2277	2277	NUM
gra-1903	36	21	8160	8160	NUM
gra-1903	36	22	•	•	NOUN
gra-1903	36	23	doi	doi	NOUN
gra-1903	36	24	:	:	PUNCT
gra-1903	36	25	10.36106	10.36106	NUM
gra-1903	36	26	/	/	SYM
gra-1903	36	27	gjra	gjra	NOUN
gra-1903	36	28	shrimali	shrimali	VERB
gra-1903	36	29	lalit	lalit	PROPN
gra-1903	36	30	*	*	PROPN
gra-1903	36	31	professor	professor	NOUN
gra-1903	36	32	,	,	PUNCT
gra-1903	36	33	department	department	NOUN
gra-1903	36	34	of	of	ADP
gra-1903	36	35	general	general	PROPN
gra-1903	36	36	medicine	medicine	PROPN
gra-1903	36	37	geetanjali	geetanjali	PROPN
gra-1903	36	38	medical	medical	PROPN
gra-1903	36	39	college	college	PROPN
gra-1903	36	40	and	and	CCONJ
gra-1903	36	41	hospital	hospital	NOUN
gra-1903	36	42	udaipur	udaipur	NOUN
gra-1903	36	43	(	(	PUNCT
gra-1903	36	44	rajasthan	rajasthan	PROPN
gra-1903	36	45	)	)	PUNCT
gra-1903	36	46	india	india	PROPN
gra-1903	36	47	*	*	PUNCT
gra-1903	36	48	corresponding	correspond	VERB
gra-1903	36	49	author	author	NOUN
gra-1903	36	50	agarwal	agarwal	PROPN
gra-1903	36	51	ankit	ankit	PROPN
gra-1903	36	52	assistant	assistant	PROPN
gra-1903	36	53	professor	professor	NOUN
gra-1903	36	54	,	,	PUNCT
gra-1903	36	55	department	department	NOUN
gra-1903	36	56	of	of	ADP
gra-1903	36	57	oncology	oncology	NOUN
gra-1903	36	58	,	,	PUNCT
gra-1903	36	59	geetanjali	geetanjali	VERB
gra-1903	36	60	medical	medical	ADJ
gra-1903	36	61	college	college	PROPN
gra-1903	36	62	and	and	CCONJ
gra-1903	36	63	hospital	hospital	NOUN
gra-1903	36	64	udaipur	udaipur	NOUN
gra-1903	36	65	(	(	PUNCT
gra-1903	36	66	rajasthan	rajasthan	PROPN
gra-1903	36	67	)	)	PUNCT
gra-1903	36	68	india	india	PROPN
gra-1903	36	69	type	type	NOUN
gra-1903	36	70	no	no	INTJ
gra-1903	36	71	.	.	PUNCT
gra-1903	37	1	%	%	NOUN
gra-1903	37	2	adenocarcinoma	adenocarcinoma	NOUN
gra-1903	37	3	38	38	NUM
gra-1903	37	4	51.35	51.35	NUM
gra-1903	37	5	60	60	NUM
gra-1903	37	6	x	x	NOUN
gra-1903	37	7	gjra	gjra	ADJ
gra-1903	37	8	global	global	ADJ
gra-1903	37	9	journal	journal	PROPN
gra-1903	37	10	for	for	ADP
gra-1903	37	11	research	research	NOUN
gra-1903	37	12	analysis	analysis	NOUN
gra-1903	37	13	table	table	NOUN
gra-1903	37	14	2	2	NUM
gra-1903	37	15	comparison	comparison	NOUN
gra-1903	37	16	between	between	ADP
gra-1903	37	17	various	various	ADJ
gra-1903	37	18	types	type	NOUN
gra-1903	37	19	of	of	ADP
gra-1903	37	20	lung	lung	NOUN
gra-1903	37	21	cancer	cancer	PROPN
gra-1903	37	22	&	&	CCONJ
gra-1903	37	23	cea	cea	PROPN
gra-1903	37	24	table	table	PROPN
gra-1903	37	25	3	3	NUM
gra-1903	37	26	cea	cea	PROPN
gra-1903	37	27	level	level	NOUN
gra-1903	37	28	in	in	ADP
gra-1903	37	29	correlation	correlation	NOUN
gra-1903	37	30	with	with	ADP
gra-1903	37	31	metastasis	metastasis	NOUN
gra-1903	37	32	table	table	NOUN
gra-1903	37	33	4	4	NUM
gra-1903	37	34	comparison	comparison	NOUN
gra-1903	37	35	between	between	ADP
gra-1903	37	36	various	various	ADJ
gra-1903	37	37	stages	stage	NOUN
gra-1903	37	38	of	of	ADP
gra-1903	37	39	lung	lung	NOUN
gra-1903	37	40	cancer	cancer	NOUN
gra-1903	37	41	&	&	CCONJ
gra-1903	37	42	cea	cea	PROPN
gra-1903	37	43	discussion	discussion	PROPN
gra-1903	37	44	serum	serum	VERB
gra-1903	37	45	tumour	tumour	NOUN
gra-1903	37	46	markers	marker	NOUN
gra-1903	37	47	are	be	AUX
gra-1903	37	48	of	of	ADP
gra-1903	37	49	signicance	signicance	NOUN
gra-1903	37	50	to	to	ADP
gra-1903	37	51	the	the	DET
gra-1903	37	52	clinician	clinician	NOUN
gra-1903	37	53	in	in	ADP
gra-1903	37	54	treating	treat	VERB
gra-1903	37	55	patients	patient	NOUN
gra-1903	37	56	with	with	ADP
gra-1903	37	57	cancer	cancer	NOUN
gra-1903	37	58	.	.	PUNCT
gra-1903	38	1	in	in	ADP
gra-1903	38	2	oncology	oncology	NOUN
gra-1903	38	3	set	set	VERB
gra-1903	38	4	up	up	ADP
gra-1903	38	5	serum	serum	NOUN
gra-1903	38	6	tumour	tumour	PROPN
gra-1903	38	7	markers	marker	NOUN
gra-1903	38	8	aid	aid	NOUN
gra-1903	38	9	in	in	ADP
gra-1903	38	10	the	the	DET
gra-1903	38	11	diagnosis	diagnosis	NOUN
gra-1903	38	12	,	,	PUNCT
gra-1903	38	13	pathologic	pathologic	ADJ
gra-1903	38	14	classications	classication	NOUN
gra-1903	38	15	,	,	PUNCT
gra-1903	38	16	and	and	CCONJ
gra-1903	38	17	evaluation	evaluation	NOUN
gra-1903	38	18	of	of	ADP
gra-1903	38	19	the	the	DET
gra-1903	38	20	stage	stage	NOUN
gra-1903	38	21	of	of	ADP
gra-1903	38	22	disease	disease	NOUN
gra-1903	38	23	and	and	CCONJ
gra-1903	38	24	prognosis	prognosis	NOUN
gra-1903	38	25	.lung	.lung	NUM
gra-1903	38	26	cancer	cancer	NOUN
gra-1903	38	27	being	be	AUX
gra-1903	38	28	the	the	DET
gra-1903	38	29	leading	lead	VERB
gra-1903	38	30	cause	cause	NOUN
gra-1903	38	31	of	of	ADP
gra-1903	38	32	cancer	cancer	NOUN
gra-1903	38	33	death	death	NOUN
gra-1903	38	34	in	in	ADP
gra-1903	38	35	both	both	DET
gra-1903	38	36	men	man	NOUN
gra-1903	38	37	and	and	CCONJ
gra-1903	38	38	women	woman	NOUN
gra-1903	38	39	needs	need	VERB
gra-1903	38	40	to	to	PART
gra-1903	38	41	be	be	AUX
gra-1903	38	42	evaluated	evaluate	VERB
gra-1903	38	43	based	base	VERB
gra-1903	38	44	on	on	ADP
gra-1903	38	45	indices	index	NOUN
gra-1903	38	46	used	use	VERB
gra-1903	38	47	for	for	ADP
gra-1903	38	48	4diagnosis	4diagnosis	NUM
gra-1903	38	49	,	,	PUNCT
gra-1903	38	50	prognosis	prognosis	NOUN
gra-1903	38	51	,	,	PUNCT
gra-1903	38	52	choice	choice	NOUN
gra-1903	38	53	of	of	ADP
gra-1903	38	54	therapy	therapy	NOUN
gra-1903	38	55	the	the	DET
gra-1903	38	56	general	general	ADJ
gra-1903	38	57	trend	trend	NOUN
gra-1903	38	58	of	of	ADP
gra-1903	38	59	male	male	ADJ
gra-1903	38	60	patients	patient	NOUN
gra-1903	38	61	is	be	AUX
gra-1903	38	62	due	due	ADJ
gra-1903	38	63	to	to	ADP
gra-1903	38	64	various	various	ADJ
gra-1903	38	65	reasons	reason	NOUN
gra-1903	38	66	including	include	VERB
gra-1903	38	67	tobacco	tobacco	NOUN
gra-1903	38	68	smoking	smoking	NOUN
gra-1903	38	69	and	and	CCONJ
gra-1903	38	70	most	most	ADV
gra-1903	38	71	commonly	commonly	ADV
gra-1903	38	72	seen	see	VERB
gra-1903	38	73	in	in	ADP
gra-1903	38	74	the	the	DET
gra-1903	38	75	age	age	NOUN
gra-1903	38	76	group	group	NOUN
gra-1903	38	77	of	of	ADP
gra-1903	38	78	3060yrs	3060yrs	NUM
gra-1903	38	79	and	and	CCONJ
gra-1903	38	80	due	due	ADP
gra-1903	38	81	to	to	ADP
gra-1903	38	82	lack	lack	NOUN
gra-1903	38	83	of	of	ADP
gra-1903	38	84	awareness	awareness	NOUN
gra-1903	38	85	of	of	ADP
gra-1903	38	86	the	the	DET
gra-1903	38	87	ill	ill	ADJ
gra-1903	38	88	effects	effect	NOUN
gra-1903	38	89	of	of	ADP
gra-1903	38	90	tobacco	tobacco	NOUN
gra-1903	38	91	5smoking	5smoking	NUM
gra-1903	38	92	in	in	ADP
gra-1903	38	93	our	our	PRON
gra-1903	38	94	study	study	NOUN
gra-1903	38	95	observed	observe	VERB
gra-1903	38	96	age	age	NOUN
gra-1903	38	97	group	group	NOUN
gra-1903	38	98	among	among	ADP
gra-1903	38	99	patients	patient	NOUN
gra-1903	38	100	with	with	ADP
gra-1903	38	101	lung	lung	NOUN
gra-1903	38	102	cancer	cancer	NOUN
gra-1903	38	103	is	be	AUX
gra-1903	38	104	in	in	ADP
gra-1903	38	105	between	between	ADP
gra-1903	38	106	51	51	NUM
gra-1903	38	107	-	-	SYM
gra-1903	38	108	60	60	NUM
gra-1903	38	109	years	year	NOUN
gra-1903	38	110	(	(	PUNCT
gra-1903	38	111	41.89%)range	41.89%)range	NOUN
gra-1903	39	1	6with	6with	ADP
gra-1903	39	2	male	male	ADJ
gra-1903	39	3	preponderance	preponderance	NOUN
gra-1903	39	4	(	(	PUNCT
gra-1903	39	5	91.89	91.89	NUM
gra-1903	39	6	%	%	NOUN
gra-1903	39	7	)	)	PUNCT
gra-1903	39	8	.	.	PUNCT
gra-1903	40	1	oscar	oscar	VERB
gra-1903	40	2	arrieta	arrieta	PROPN
gra-1903	40	3	et	et	PROPN
gra-1903	40	4	al	al	PROPN
gra-1903	40	5	study	study	PROPN
gra-1903	40	6	in	in	ADP
gra-1903	40	7	the	the	DET
gra-1903	40	8	year	year	NOUN
gra-1903	40	9	2013	2013	NUM
gra-1903	40	10	documented	document	VERB
gra-1903	40	11	the	the	DET
gra-1903	40	12	male	male	ADJ
gra-1903	40	13	preponderance	preponderance	NOUN
gra-1903	40	14	(	(	PUNCT
gra-1903	40	15	54.4	54.4	NUM
gra-1903	40	16	%	%	NOUN
gra-1903	40	17	)	)	PUNCT
gra-1903	40	18	and	and	CCONJ
gra-1903	40	19	age	age	NOUN
gra-1903	40	20	group	group	NOUN
gra-1903	40	21	being	be	AUX
gra-1903	40	22	in	in	ADP
gra-1903	40	23	between	between	ADP
gra-1903	40	24	47	47	NUM
gra-1903	40	25	-	-	PUNCT
gra-1903	40	26	60years	60years	NUM
gra-1903	40	27	(	(	PUNCT
gra-1903	40	28	59.4	59.4	NUM
gra-1903	40	29	%	%	NOUN
gra-1903	40	30	)	)	PUNCT
gra-1903	40	31	to	to	PART
gra-1903	40	32	be	be	AUX
gra-1903	40	33	affected	affect	VERB
gra-1903	40	34	more	more	ADJ
gra-1903	40	35	than	than	ADP
gra-1903	40	36	other	other	ADJ
gra-1903	40	37	age	age	NOUN
gra-1903	40	38	groups	group	NOUN
gra-1903	40	39	,	,	PUNCT
gra-1903	40	40	which	which	PRON
gra-1903	40	41	is	be	AUX
gra-1903	40	42	similar	similar	ADJ
gra-1903	40	43	to	to	ADP
gra-1903	40	44	the	the	DET
gra-1903	40	45	present	present	ADJ
gra-1903	40	46	study	study	NOUN
gra-1903	40	47	.	.	PUNCT
gra-1903	41	1	our	our	PRON
gra-1903	41	2	study	study	NOUN
gra-1903	41	3	conducted	conduct	VERB
gra-1903	41	4	on	on	ADP
gra-1903	41	5	74	74	NUM
gra-1903	41	6	patients	patient	NOUN
gra-1903	41	7	showed	show	VERB
gra-1903	41	8	69	69	NUM
gra-1903	41	9	patients	patient	NOUN
gra-1903	41	10	(	(	PUNCT
gra-1903	41	11	93.24	93.24	NUM
gra-1903	41	12	%	%	NOUN
gra-1903	41	13	)	)	PUNCT
gra-1903	41	14	to	to	PART
gra-1903	41	15	be	be	AUX
gra-1903	41	16	associated	associate	VERB
gra-1903	41	17	with	with	ADP
gra-1903	41	18	smoking	smoking	NOUN
gra-1903	41	19	while	while	SCONJ
gra-1903	41	20	remaining	remain	VERB
gra-1903	41	21	5	5	NUM
gra-1903	41	22	(	(	PUNCT
gra-1903	41	23	6.75	6.75	NUM
gra-1903	41	24	%	%	NOUN
gra-1903	41	25	)	)	PUNCT
gra-1903	41	26	were	be	AUX
gra-1903	41	27	found	find	VERB
gra-1903	41	28	to	to	PART
gra-1903	41	29	be	be	AUX
gra-1903	41	30	non	non	NOUN
gra-1903	41	31	-	-	NOUN
gra-1903	41	32	smokers	smoker	NOUN
gra-1903	41	33	by	by	ADP
gra-1903	41	34	history	history	NOUN
gra-1903	41	35	7and	7and	PROPN
gra-1903	41	36	examination	examination	NOUN
gra-1903	41	37	.	.	PUNCT
gra-1903	42	1	in	in	ADP
gra-1903	42	2	konstantinos	konstantinos	PROPN
gra-1903	42	3	charalabopoulos	charalabopoulos	PROPN
gra-1903	42	4	et	et	PROPN
gra-1903	42	5	al	al	PROPN
gra-1903	42	6	study	study	PROPN
gra-1903	42	7	,	,	PUNCT
gra-1903	42	8	46	46	NUM
gra-1903	42	9	patients	patient	NOUN
gra-1903	42	10	were	be	AUX
gra-1903	42	11	smokers	smoker	NOUN
gra-1903	42	12	(	(	PUNCT
gra-1903	42	13	92	92	NUM
gra-1903	42	14	%	%	NOUN
gra-1903	42	15	)	)	PUNCT
gra-1903	42	16	among	among	ADP
gra-1903	42	17	50	50	NUM
gra-1903	42	18	patients	patient	NOUN
gra-1903	42	19	suffering	suffer	VERB
gra-1903	42	20	from	from	ADP
gra-1903	42	21	lung	lung	NOUN
gra-1903	42	22	cancer	cancer	NOUN
gra-1903	42	23	,	,	PUNCT
gra-1903	42	24	remaining	remain	VERB
gra-1903	42	25	4	4	NUM
gra-1903	42	26	patients	patient	NOUN
gra-1903	42	27	(	(	PUNCT
gra-1903	42	28	8	8	NUM
gra-1903	42	29	%	%	NOUN
gra-1903	42	30	)	)	PUNCT
gra-1903	42	31	were	be	AUX
gra-1903	42	32	non	non	NOUN
gra-1903	42	33	-	-	NOUN
gra-1903	42	34	smokers	smoker	NOUN
gra-1903	42	35	.	.	PUNCT
gra-1903	43	1	adenocarcinoma	adenocarcinoma	PROPN
gra-1903	43	2	is	be	AUX
gra-1903	43	3	the	the	DET
gra-1903	43	4	most	most	ADV
gra-1903	43	5	common	common	ADJ
gra-1903	43	6	histolo	histolo	ADJ
gra-1903	43	7	gical	gical	ADJ
gra-1903	43	8	group	group	NOUN
gra-1903	43	9	in	in	ADP
gra-1903	43	10	men	man	NOUN
gra-1903	43	11	and	and	CCONJ
gra-1903	43	12	women	woman	NOUN
gra-1903	43	13	worldwide	worldwide	ADV
gra-1903	43	14	.	.	PUNCT
gra-1903	44	1	studies	study	NOUN
gra-1903	44	2	conducted	conduct	VERB
gra-1903	44	3	8	8	NUM
gra-1903	44	4	9	9	NUM
gra-1903	44	5	10by	10by	NOUN
gra-1903	44	6	jae	jae	PROPN
gra-1903	44	7	jun	jun	PROPN
gra-1903	44	8	kim	kim	PROPN
gra-1903	44	9	et	et	PROPN
gra-1903	44	10	al	al	PROPN
gra-1903	44	11	,	,	PUNCT
gra-1903	44	12	chen	chen	PROPN
gra-1903	44	13	et	et	PROPN
gra-1903	44	14	al	al	PROPN
gra-1903	44	15	zaleska	zaleska	PROPN
gra-1903	44	16	et	et	PROPN
gra-1903	44	17	al	al	PROPN
gra-1903	44	18	all	all	PRON
gra-1903	44	19	showed	show	VERB
gra-1903	44	20	that	that	SCONJ
gra-1903	44	21	adenocarcinoma	adenocarcinoma	NOUN
gra-1903	44	22	is	be	AUX
gra-1903	44	23	the	the	DET
gra-1903	44	24	commonest	commonest	NOUN
gra-1903	44	25	type	type	NOUN
gra-1903	44	26	of	of	ADP
gra-1903	44	27	lung	lung	NOUN
gra-1903	44	28	cancer	cancer	NOUN
gra-1903	44	29	with	with	ADP
gra-1903	44	30	51.8	51.8	NUM
gra-1903	44	31	%	%	NOUN
gra-1903	44	32	,	,	PUNCT
gra-1903	44	33	72.9	72.9	NUM
gra-1903	44	34	%	%	NOUN
gra-1903	44	35	and	and	CCONJ
gra-1903	44	36	48.10%respectively	48.10%respectively	ADV
gra-1903	44	37	which	which	PRON
gra-1903	44	38	is	be	AUX
gra-1903	44	39	similar	similar	ADJ
gra-1903	44	40	to	to	ADP
gra-1903	44	41	the	the	DET
gra-1903	44	42	present	present	ADJ
gra-1903	44	43	study	study	NOUN
gra-1903	44	44	where	where	SCONJ
gra-1903	44	45	51.35	51.35	NUM
gra-1903	44	46	%	%	NOUN
gra-1903	44	47	were	be	AUX
gra-1903	44	48	adenocarcinoma	adenocarcinoma	ADJ
gra-1903	44	49	.	.	PUNCT
gra-1903	45	1	in	in	ADP
gra-1903	45	2	our	our	PRON
gra-1903	45	3	study	study	NOUN
gra-1903	45	4	,	,	PUNCT
gra-1903	45	5	30	30	NUM
gra-1903	45	6	(	(	PUNCT
gra-1903	45	7	71.43	71.43	NUM
gra-1903	45	8	%	%	NOUN
gra-1903	45	9	)	)	PUNCT
gra-1903	45	10	cases	case	NOUN
gra-1903	45	11	out	out	ADP
gra-1903	45	12	of	of	ADP
gra-1903	45	13	42	42	NUM
gra-1903	45	14	of	of	ADP
gra-1903	45	15	stage	stage	NOUN
gra-1903	45	16	iv	iv	NUM
gra-1903	45	17	showed	show	VERB
gra-1903	45	18	10higher	10higher	NUM
gra-1903	45	19	cea	cea	PROPN
gra-1903	45	20	level	level	NOUN
gra-1903	45	21	than	than	ADP
gra-1903	45	22	normal	normal	ADJ
gra-1903	45	23	.	.	PUNCT
gra-1903	46	1	zaleska	zaleska	NOUN
gra-1903	46	2	et	et	PROPN
gra-1903	46	3	al	al	PROPN
gra-1903	46	4	.	.	PUNCT
gra-1903	47	1	in	in	ADP
gra-1903	47	2	the	the	DET
gra-1903	47	3	year	year	NOUN
gra-1903	47	4	2010	2010	NUM
gra-1903	47	5	showed	show	VERB
gra-1903	47	6	that	that	SCONJ
gra-1903	47	7	33	33	NUM
gra-1903	47	8	(	(	PUNCT
gra-1903	47	9	41.77	41.77	NUM
gra-1903	47	10	%	%	NOUN
gra-1903	47	11	)	)	PUNCT
gra-1903	47	12	cases	case	NOUN
gra-1903	47	13	out	out	ADP
gra-1903	47	14	of	of	ADP
gra-1903	47	15	79	79	NUM
gra-1903	47	16	of	of	ADP
gra-1903	47	17	stage	stage	NOUN
gra-1903	47	18	iv	iv	NUM
gra-1903	47	19	showed	show	VERB
gra-1903	47	20	higher	high	ADJ
gra-1903	47	21	cea	cea	PROPN
gra-1903	47	22	level	level	NOUN
gra-1903	47	23	than	than	ADP
gra-1903	47	24	normal	normal	ADJ
gra-1903	47	25	with	with	ADP
gra-1903	47	26	p	p	NOUN
gra-1903	47	27	value	value	NOUN
gra-1903	47	28	(	(	PUNCT
gra-1903	47	29	<	<	X
gra-1903	47	30	0.024	0.024	NUM
gra-1903	47	31	)	)	PUNCT
gra-1903	47	32	.	.	PUNCT
gra-1903	48	1	study	study	NOUN
gra-1903	48	2	by	by	ADP
gra-1903	48	3	6arrieta	6arrieta	NUM
gra-1903	48	4	et	et	NOUN
gra-1903	48	5	al	al	PROPN
gra-1903	48	6	also	also	ADV
gra-1903	48	7	showed	show	VERB
gra-1903	48	8	similar	similar	ADJ
gra-1903	48	9	observation	observation	NOUN
gra-1903	48	10	where	where	SCONJ
gra-1903	48	11	stage	stage	NOUN
gra-1903	48	12	iv	iv	PRON
gra-1903	48	13	showed	show	VERB
gra-1903	48	14	higher	high	ADJ
gra-1903	48	15	cea	cea	PROPN
gra-1903	48	16	levels	level	NOUN
gra-1903	48	17	than	than	ADP
gra-1903	48	18	normal	normal	ADJ
gra-1903	48	19	with	with	ADP
gra-1903	48	20	a	a	DET
gra-1903	48	21	p	p	NOUN
gra-1903	48	22	value	value	NOUN
gra-1903	48	23	(	(	PUNCT
gra-1903	48	24	<	<	NOUN
gra-1903	48	25	0.03	0.03	NUM
gra-1903	48	26	)	)	PUNCT
gra-1903	48	27	all	all	DET
gra-1903	48	28	5	5	NUM
gra-1903	48	29	cases	case	NOUN
gra-1903	48	30	of	of	ADP
gra-1903	48	31	stage	stage	NOUN
gra-1903	48	32	iiib	iiib	NOUN
gra-1903	48	33	showed	show	VERB
gra-1903	48	34	higher	high	ADJ
gra-1903	48	35	cea	cea	PROPN
gra-1903	48	36	level	level	NOUN
gra-1903	48	37	than	than	ADP
gra-1903	48	38	normal	normal	ADJ
gra-1903	48	39	.	.	PUNCT
gra-1903	49	1	out	out	ADP
gra-1903	49	2	of	of	ADP
gra-1903	49	3	7	7	NUM
gra-1903	49	4	cases	case	NOUN
gra-1903	49	5	of	of	ADP
gra-1903	49	6	iiia	iiia	NOUN
gra-1903	49	7	4	4	NUM
gra-1903	49	8	(	(	PUNCT
gra-1903	49	9	57.14	57.14	NUM
gra-1903	49	10	%	%	NOUN
gra-1903	49	11	)	)	PUNCT
gra-1903	49	12	showed	show	VERB
gra-1903	49	13	higher	high	ADJ
gra-1903	49	14	cea	cea	PROPN
gra-1903	49	15	level	level	NOUN
gra-1903	49	16	than	than	ADP
gra-1903	49	17	normal	normal	ADJ
gra-1903	49	18	.	.	PUNCT
gra-1903	50	1	a	a	DET
gra-1903	50	2	study	study	NOUN
gra-1903	50	3	conducted	conduct	VERB
gra-1903	50	4	by	by	ADP
gra-1903	50	5	11aoyagi	11aoyagi	PROPN
gra-1903	51	1	k	k	PROPN
gra-1903	52	1	in	in	ADP
gra-1903	52	2	the	the	DET
gra-1903	52	3	year	year	NOUN
gra-1903	52	4	1999	1999	NUM
gra-1903	52	5	observed	observe	VERB
gra-1903	52	6	that	that	SCONJ
gra-1903	52	7	cea	cea	PROPN
gra-1903	52	8	levels	levels	PROPN
gra-1903	52	9	estimation	estimation	NOUN
gra-1903	52	10	in	in	ADP
gra-1903	52	11	stage	stage	NOUN
gra-1903	52	12	i	i	PROPN
gra-1903	52	13	-	-	PUNCT
gra-1903	52	14	iii	iii	PROPN
gra-1903	52	15	lung	lung	NOUN
gra-1903	52	16	cancer	cancer	NOUN
gra-1903	52	17	patients	patient	NOUN
gra-1903	52	18	to	to	PART
gra-1903	52	19	be	be	AUX
gra-1903	52	20	statistically	statistically	ADV
gra-1903	52	21	signicant	signicant	ADJ
gra-1903	52	22	with	with	ADP
gra-1903	52	23	p	p	NOUN
gra-1903	52	24	value	value	NOUN
gra-1903	52	25	of	of	ADP
gra-1903	52	26	(	(	PUNCT
gra-1903	52	27	0.041	0.041	NUM
gra-1903	52	28	)	)	PUNCT
gra-1903	52	29	some	some	DET
gra-1903	52	30	studies	study	NOUN
gra-1903	52	31	have	have	AUX
gra-1903	52	32	reported	report	VERB
gra-1903	52	33	that	that	SCONJ
gra-1903	52	34	serum	serum	PROPN
gra-1903	52	35	cea	cea	PROPN
gra-1903	52	36	levels	level	NOUN
gra-1903	52	37	were	be	AUX
gra-1903	52	38	signicantly	signicantly	ADV
gra-1903	52	39	higher	high	ADJ
gra-1903	52	40	in	in	ADP
gra-1903	52	41	patients	patient	NOUN
gra-1903	52	42	with	with	ADP
gra-1903	52	43	metastatic	metastatic	ADJ
gra-1903	52	44	disease	disease	NOUN
gra-1903	52	45	as	as	SCONJ
gra-1903	52	46	compared	compare	VERB
gra-1903	52	47	to	to	ADP
gra-1903	52	48	patients	patient	NOUN
gra-1903	52	49	with	with	ADP
gra-1903	52	50	non	non	ADJ
gra-1903	52	51	-	-	ADJ
gra-1903	52	52	metastatic	metastatic	ADJ
gra-1903	52	53	disease	disease	NOUN
gra-1903	52	54	.	.	PUNCT
gra-1903	53	1	(	(	PUNCT
gra-1903	53	2	91	91	NUM
gra-1903	53	3	)	)	PUNCT
gra-1903	53	4	(	(	PUNCT
gra-1903	53	5	92	92	NUM
gra-1903	53	6	)	)	PUNCT
gra-1903	53	7	12(93	12(93	NOUN
gra-1903	53	8	)	)	PUNCT
gra-1903	53	9	study	study	NOUN
gra-1903	53	10	by	by	ADP
gra-1903	53	11	ahmet	ahmet	PROPN
gra-1903	53	12	et	et	PROPN
gra-1903	53	13	al	al	PROPN
gra-1903	53	14	did	do	AUX
gra-1903	53	15	not	not	PART
gra-1903	53	16	show	show	VERB
gra-1903	53	17	signicant	signicant	ADJ
gra-1903	53	18	difference	difference	NOUN
gra-1903	53	19	in	in	ADP
gra-1903	53	20	serum	serum	PROPN
gra-1903	53	21	cea	cea	PROPN
gra-1903	53	22	levels	level	NOUN
gra-1903	53	23	between	between	ADP
gra-1903	53	24	stage	stage	NOUN
gra-1903	53	25	iii	iii	NOUN
gra-1903	53	26	and	and	CCONJ
gra-1903	53	27	stage	stage	NOUN
gra-1903	53	28	iv	iv	NUM
gra-1903	53	29	,	,	PUNCT
gra-1903	53	30	which	which	PRON
gra-1903	53	31	is	be	AUX
gra-1903	53	32	similar	similar	ADJ
gra-1903	53	33	to	to	ADP
gra-1903	53	34	our	our	PRON
gra-1903	53	35	study	study	NOUN
gra-1903	53	36	.	.	PUNCT
gra-1903	54	1	in	in	ADP
gra-1903	54	2	the	the	DET
gra-1903	54	3	present	present	ADJ
gra-1903	54	4	study	study	NOUN
gra-1903	54	5	24	24	NUM
gra-1903	54	6	out	out	ADP
gra-1903	54	7	of	of	ADP
gra-1903	54	8	42	42	NUM
gra-1903	54	9	patients	patient	NOUN
gra-1903	54	10	were	be	AUX
gra-1903	54	11	adenocarcinoma	adenocarcinoma	ADJ
gra-1903	54	12	type	type	NOUN
gra-1903	54	13	with	with	ADP
gra-1903	54	14	distant	distant	ADJ
gra-1903	54	15	metastasis	metastasis	NOUN
gra-1903	54	16	which	which	PRON
gra-1903	54	17	is	be	AUX
gra-1903	54	18	similar	similar	ADJ
gra-1903	54	19	to	to	ADP
gra-1903	54	20	the	the	DET
gra-1903	54	21	study	study	NOUN
gra-1903	54	22	conducted	conduct	VERB
gra-1903	54	23	by	by	ADP
gra-1903	54	24	arrieta	arrieta	PROPN
gra-1903	54	25	et	et	PROPN
gra-1903	54	26	al	al	PROPN
gra-1903	54	27	(	(	PUNCT
gra-1903	54	28	73	73	NUM
gra-1903	54	29	)	)	PUNCT
gra-1903	54	30	.	.	PUNCT
gra-1903	55	1	higher	high	ADJ
gra-1903	55	2	than	than	ADP
gra-1903	55	3	normal	normal	ADJ
gra-1903	55	4	level	level	NOUN
gra-1903	55	5	of	of	ADP
gra-1903	55	6	cea	cea	PROPN
gra-1903	55	7	was	be	AUX
gra-1903	55	8	seen	see	VERB
gra-1903	55	9	in	in	ADP
gra-1903	55	10	all	all	DET
gra-1903	55	11	3	3	NUM
gra-1903	55	12	(	(	PUNCT
gra-1903	55	13	100	100	NUM
gra-1903	55	14	%	%	NOUN
gra-1903	55	15	)	)	PUNCT
gra-1903	55	16	patients	patient	NOUN
gra-1903	55	17	of	of	ADP
gra-1903	55	18	pleural	pleural	ADJ
gra-1903	55	19	metastasis	metastasis	NOUN
gra-1903	55	20	followed	follow	VERB
gra-1903	55	21	by	by	ADP
gra-1903	55	22	brain	brain	NOUN
gra-1903	55	23	metastasis	metastasis	NOUN
gra-1903	55	24	were	be	AUX
gra-1903	55	25	5	5	NUM
gra-1903	55	26	(	(	PUNCT
gra-1903	55	27	83.33	83.33	NUM
gra-1903	55	28	%	%	NOUN
gra-1903	55	29	)	)	PUNCT
gra-1903	55	30	out	out	ADP
gra-1903	55	31	of	of	ADP
gra-1903	55	32	6	6	NUM
gra-1903	55	33	patients	patient	NOUN
gra-1903	55	34	,	,	PUNCT
gra-1903	55	35	liver	liver	NOUN
gra-1903	55	36	metastasis	metastasis	NOUN
gra-1903	55	37	were	be	AUX
gra-1903	55	38	5	5	NUM
gra-1903	55	39	(	(	PUNCT
gra-1903	55	40	71.43	71.43	NUM
gra-1903	55	41	%	%	NOUN
gra-1903	55	42	)	)	PUNCT
gra-1903	55	43	out	out	ADP
gra-1903	55	44	of	of	ADP
gra-1903	55	45	7	7	NUM
gra-1903	55	46	patients	patient	NOUN
gra-1903	55	47	,	,	PUNCT
gra-1903	55	48	adrenal	adrenal	ADJ
gra-1903	55	49	metastasis	metastasis	NOUN
gra-1903	55	50	were	be	AUX
gra-1903	55	51	6	6	NUM
gra-1903	55	52	(	(	PUNCT
gra-1903	55	53	60	60	NUM
gra-1903	55	54	%	%	NOUN
gra-1903	55	55	)	)	PUNCT
gra-1903	55	56	out	out	ADP
gra-1903	55	57	of	of	ADP
gra-1903	55	58	10	10	NUM
gra-1903	55	59	patients	patient	NOUN
gra-1903	55	60	,	,	PUNCT
gra-1903	55	61	bone	bone	NOUN
gra-1903	55	62	metastasis	metastasis	NOUN
gra-1903	55	63	were	be	AUX
gra-1903	55	64	4	4	NUM
gra-1903	55	65	(	(	PUNCT
gra-1903	55	66	57.14	57.14	NUM
gra-1903	55	67	%	%	NOUN
gra-1903	55	68	)	)	PUNCT
gra-1903	55	69	out	out	ADP
gra-1903	55	70	of	of	ADP
gra-1903	55	71	7	7	NUM
gra-1903	55	72	patients	patient	NOUN
gra-1903	55	73	showed	show	VERB
gra-1903	55	74	higher	high	ADJ
gra-1903	55	75	than	than	ADP
gra-1903	55	76	normal	normal	ADJ
gra-1903	55	77	level	level	NOUN
gra-1903	55	78	of	of	ADP
gra-1903	55	79	cea	cea	PROPN
gra-1903	55	80	,	,	PUNCT
gra-1903	55	81	7	7	NUM
gra-1903	55	82	(	(	PUNCT
gra-1903	55	83	77.78	77.78	NUM
gra-1903	55	84	%	%	NOUN
gra-1903	55	85	)	)	PUNCT
gra-1903	55	86	in	in	ADP
gra-1903	55	87	the	the	DET
gra-1903	55	88	present	present	ADJ
gra-1903	55	89	study	study	NOUN
gra-1903	55	90	.	.	PUNCT
gra-1903	56	1	13a	13a	PROPN
gra-1903	56	2	study	study	VERB
gra-1903	56	3	by	by	ADP
gra-1903	56	4	arrieta	arrieta	PROPN
gra-1903	56	5	et	et	PROPN
gra-1903	56	6	al	al	PROPN
gra-1903	56	7	-studying	-studye	VERB
gra-1903	56	8	metastasis	metastasis	NOUN
gra-1903	56	9	to	to	ADP
gra-1903	56	10	brain	brain	NOUN
gra-1903	56	11	showed	show	VERB
gra-1903	56	12	that	that	SCONJ
gra-1903	56	13	brain	brain	NOUN
gra-1903	56	14	metastasis	metastasis	NOUN
gra-1903	56	15	in	in	ADP
gra-1903	56	16	patients	patient	NOUN
gra-1903	56	17	with	with	ADP
gra-1903	56	18	adenocarcinoma	adenocarcinoma	NOUN
gra-1903	56	19	subtype	subtype	NOUN
gra-1903	56	20	and	and	CCONJ
gra-1903	56	21	higher	high	ADJ
gra-1903	56	22	than	than	ADP
gra-1903	56	23	normal	normal	ADJ
gra-1903	56	24	level	level	NOUN
gra-1903	56	25	of	of	ADP
gra-1903	56	26	cea	cea	PROPN
gra-1903	56	27	at	at	ADP
gra-1903	56	28	diagnosis	diagnosis	NOUN
gra-1903	56	29	.	.	PUNCT
gra-1903	57	1	12study	12study	NUM
gra-1903	57	2	by	by	ADP
gra-1903	57	3	ahmet	ahmet	PROPN
gra-1903	57	4	et	et	PROPN
gra-1903	57	5	al	al	PROPN
gra-1903	57	6	concluded	conclude	VERB
gra-1903	57	7	that	that	SCONJ
gra-1903	57	8	higher	high	ADJ
gra-1903	57	9	than	than	ADP
gra-1903	57	10	normal	normal	ADJ
gra-1903	57	11	level	level	NOUN
gra-1903	57	12	of	of	ADP
gra-1903	57	13	serum	serum	PROPN
gra-1903	57	14	cea	cea	PROPN
gra-1903	57	15	were	be	AUX
gra-1903	57	16	signicant	signicant	ADJ
gra-1903	57	17	for	for	ADP
gra-1903	57	18	predicting	predict	VERB
gra-1903	57	19	distant	distant	ADJ
gra-1903	57	20	metastases	metastasis	NOUN
gra-1903	57	21	,	,	PUNCT
gra-1903	57	22	which	which	PRON
gra-1903	57	23	is	be	AUX
gra-1903	57	24	similar	similar	ADJ
gra-1903	57	25	to	to	ADP
gra-1903	57	26	the	the	DET
gra-1903	57	27	present	present	ADJ
gra-1903	57	28	study	study	NOUN
gra-1903	57	29	where	where	SCONJ
gra-1903	57	30	it	it	PRON
gra-1903	57	31	was	be	AUX
gra-1903	57	32	found	find	VERB
gra-1903	57	33	that	that	SCONJ
gra-1903	57	34	distant	distant	ADJ
gra-1903	57	35	metastasis	metastasis	NOUN
gra-1903	57	36	was	be	AUX
gra-1903	57	37	seen	see	VERB
gra-1903	57	38	in	in	ADP
gra-1903	57	39	higher	high	ADJ
gra-1903	57	40	than	than	ADP
gra-1903	57	41	normal	normal	ADJ
gra-1903	57	42	level	level	NOUN
gra-1903	57	43	of	of	ADP
gra-1903	57	44	cea	cea	PROPN
gra-1903	57	45	levels	level	NOUN
gra-1903	57	46	in	in	ADP
gra-1903	57	47	30	30	NUM
gra-1903	57	48	(	(	PUNCT
gra-1903	57	49	71.43	71.43	NUM
gra-1903	57	50	%	%	NOUN
gra-1903	57	51	)	)	PUNCT
gra-1903	57	52	patients	patient	NOUN
gra-1903	57	53	out	out	ADP
gra-1903	57	54	of	of	ADP
gra-1903	57	55	42	42	NUM
gra-1903	57	56	patients	patient	NOUN
gra-1903	57	57	of	of	ADP
gra-1903	57	58	metastasis	metastasis	NOUN
gra-1903	57	59	.	.	PUNCT
gra-1903	58	1	high	high	ADJ
gra-1903	58	2	serum	serum	PROPN
gra-1903	58	3	cea	cea	PROPN
gra-1903	58	4	levels	level	NOUN
gra-1903	58	5	suggest	suggest	VERB
gra-1903	58	6	micro	micro	ADJ
gra-1903	58	7	metastatic	metastatic	ADJ
gra-1903	58	8	disease	disease	NOUN
gra-1903	58	9	,	,	PUNCT
gra-1903	58	10	also	also	ADV
gra-1903	58	11	prognostic	prognostic	ADJ
gra-1903	58	12	values	value	NOUN
gra-1903	58	13	of	of	ADP
gra-1903	58	14	high	high	ADJ
gra-1903	58	15	cea	cea	PROPN
gra-1903	58	16	serum	serum	NOUN
gra-1903	58	17	levels	level	NOUN
gra-1903	58	18	can	can	AUX
gra-1903	58	19	13,14be	13,14be	NOUN
gra-1903	58	20	accounted	account	VERB
gra-1903	58	21	for	for	ADP
gra-1903	58	22	by	by	ADP
gra-1903	58	23	tumour	tumour	NOUN
gra-1903	58	24	change	change	NOUN
gra-1903	58	25	15a	15a	NOUN
gra-1903	58	26	study	study	NOUN
gra-1903	58	27	conducted	conduct	VERB
gra-1903	58	28	by	by	ADP
gra-1903	58	29	jiasi	jiasi	PROPN
gra-1903	58	30	wang	wang	PROPN
gra-1903	58	31	et	et	PROPN
gra-1903	58	32	al	al	PROPN
gra-1903	58	33	observed	observe	VERB
gra-1903	58	34	that	that	SCONJ
gra-1903	58	35	128	128	NUM
gra-1903	58	36	out	out	ADP
gra-1903	58	37	of	of	ADP
gra-1903	58	38	213	213	NUM
gra-1903	58	39	patients	patient	NOUN
gra-1903	58	40	showed	show	VERB
gra-1903	58	41	metastasis	metastasis	NOUN
gra-1903	58	42	in	in	ADP
gra-1903	58	43	which	which	PRON
gra-1903	58	44	49	49	NUM
gra-1903	58	45	(	(	PUNCT
gra-1903	58	46	38.3	38.3	NUM
gra-1903	58	47	%	%	NOUN
gra-1903	58	48	)	)	PUNCT
gra-1903	58	49	patients	patient	NOUN
gra-1903	58	50	were	be	AUX
gra-1903	58	51	adenocarcinoma	adenocarcinoma	ADJ
gra-1903	58	52	,	,	PUNCT
gra-1903	58	53	47	47	NUM
gra-1903	58	54	(	(	PUNCT
gra-1903	58	55	36.7	36.7	NUM
gra-1903	58	56	%	%	NOUN
gra-1903	58	57	)	)	PUNCT
gra-1903	59	1	patients	patient	NOUN
gra-1903	59	2	were	be	AUX
gra-1903	59	3	squamous	squamous	ADJ
gra-1903	59	4	cell	cell	NOUN
gra-1903	59	5	carcinoma	carcinoma	NOUN
gra-1903	59	6	and	and	CCONJ
gra-1903	59	7	24	24	NUM
gra-1903	59	8	(	(	PUNCT
gra-1903	59	9	18.8	18.8	NUM
gra-1903	59	10	%	%	NOUN
gra-1903	59	11	)	)	PUNCT
gra-1903	59	12	patients	patient	NOUN
gra-1903	59	13	were	be	AUX
gra-1903	59	14	small	small	ADJ
gra-1903	59	15	cell	cell	NOUN
gra-1903	59	16	carcinoma	carcinoma	NOUN
gra-1903	59	17	and	and	CCONJ
gra-1903	59	18	corresponds	correspond	VERB
gra-1903	59	19	with	with	ADP
gra-1903	59	20	our	our	PRON
gra-1903	59	21	study	study	NOUN
gra-1903	59	22	.	.	PUNCT
gra-1903	60	1	this	this	DET
gra-1903	60	2	study	study	NOUN
gra-1903	60	3	suggested	suggest	VERB
gra-1903	60	4	that	that	SCONJ
gra-1903	60	5	serum	serum	PROPN
gra-1903	60	6	cea	cea	PROPN
gra-1903	60	7	as	as	ADP
gra-1903	60	8	a	a	DET
gra-1903	60	9	valuable	valuable	ADJ
gra-1903	60	10	marker	marker	NOUN
gra-1903	60	11	in	in	ADP
gra-1903	60	12	the	the	DET
gra-1903	60	13	assessment	assessment	NOUN
gra-1903	60	14	of	of	ADP
gra-1903	60	15	tumour	tumour	ADJ
gra-1903	60	16	metastasis	metastasis	NOUN
gra-1903	60	17	in	in	ADP
gra-1903	60	18	lung	lung	NOUN
gra-1903	60	19	cancer	cancer	NOUN
gra-1903	60	20	patients	patient	NOUN
gra-1903	60	21	.	.	PUNCT
gra-1903	61	1	early	early	ADJ
gra-1903	61	2	identication	identication	NOUN
gra-1903	61	3	and	and	CCONJ
gra-1903	61	4	location	location	NOUN
gra-1903	61	5	of	of	ADP
gra-1903	61	6	metastasis	metastasis	NOUN
gra-1903	61	7	with	with	ADP
gra-1903	61	8	the	the	DET
gra-1903	61	9	help	help	NOUN
gra-1903	61	10	of	of	ADP
gra-1903	61	11	such	such	ADJ
gra-1903	61	12	tumour	tumour	ADJ
gra-1903	61	13	markers	marker	NOUN
gra-1903	61	14	such	such	ADJ
gra-1903	61	15	as	as	ADP
gra-1903	61	16	serum	serum	PROPN
gra-1903	61	17	cea	cea	PROPN
gra-1903	61	18	levels	level	NOUN
gra-1903	61	19	can	can	AUX
gra-1903	61	20	be	be	AUX
gra-1903	61	21	useful	useful	ADJ
gra-1903	61	22	for	for	ADP
gra-1903	61	23	clinical	clinical	ADJ
gra-1903	61	24	selection	selection	NOUN
gra-1903	61	25	of	of	ADP
gra-1903	61	26	treatment	treatment	NOUN
gra-1903	61	27	and	and	CCONJ
gra-1903	61	28	can	can	AUX
gra-1903	61	29	therefore	therefore	ADV
gra-1903	61	30	create	create	VERB
gra-1903	61	31	16better	16better	NOUN
gra-1903	61	32	prognosis	prognosis	NOUN
gra-1903	61	33	conclusion	conclusion	NOUN
gra-1903	61	34	tumour	tumour	NOUN
gra-1903	61	35	markers	marker	NOUN
gra-1903	61	36	are	be	AUX
gra-1903	61	37	related	relate	VERB
gra-1903	61	38	to	to	ADP
gra-1903	61	39	histological	histological	ADJ
gra-1903	61	40	type	type	NOUN
gra-1903	61	41	and	and	CCONJ
gra-1903	61	42	tumour	tumour	NOUN
gra-1903	61	43	staging	staging	NOUN
gra-1903	61	44	.	.	PUNCT
gra-1903	62	1	routine	routine	ADJ
gra-1903	62	2	serum	serum	PROPN
gra-1903	62	3	cea	cea	PROPN
gra-1903	62	4	testing	testing	NOUN
gra-1903	62	5	in	in	ADP
gra-1903	62	6	patient	patient	NOUN
gra-1903	62	7	with	with	ADP
gra-1903	62	8	non	non	ADJ
gra-1903	62	9	-	-	ADJ
gra-1903	62	10	small	small	ADJ
gra-1903	62	11	cell	cell	NOUN
gra-1903	62	12	lung	lung	NOUN
gra-1903	62	13	carcinoma	carcinoma	NOUN
gra-1903	62	14	than	than	ADP
gra-1903	62	15	small	small	ADJ
gra-1903	62	16	cell	cell	NOUN
gra-1903	62	17	lung	lung	NOUN
gra-1903	62	18	carcinoma	carcinoma	NOUN
gra-1903	62	19	,	,	PUNCT
gra-1903	62	20	allowing	allow	VERB
gra-1903	62	21	the	the	DET
gra-1903	62	22	identication	identication	NOUN
gra-1903	62	23	of	of	ADP
gra-1903	62	24	a	a	DET
gra-1903	62	25	signicant	signicant	ADJ
gra-1903	62	26	proportion	proportion	NOUN
gra-1903	62	27	of	of	ADP
gra-1903	62	28	patients	patient	NOUN
gra-1903	62	29	at	at	ADP
gra-1903	62	30	high	high	ADJ
gra-1903	62	31	risk	risk	NOUN
gra-1903	62	32	of	of	ADP
gra-1903	62	33	developing	develop	VERB
gra-1903	62	34	a	a	DET
gra-1903	62	35	tumour	tumour	NOUN
gra-1903	62	36	relapse	relapse	NOUN
gra-1903	62	37	being	be	AUX
gra-1903	62	38	cost	cost	NOUN
gra-1903	62	39	effective	effective	ADJ
gra-1903	62	40	.	.	PUNCT
gra-1903	63	1	cea	cea	PROPN
gra-1903	63	2	level	level	NOUN
gra-1903	63	3	estimation	estimation	NOUN
gra-1903	63	4	can	can	AUX
gra-1903	63	5	be	be	AUX
gra-1903	63	6	used	use	VERB
gra-1903	63	7	as	as	ADP
gra-1903	63	8	a	a	DET
gra-1903	63	9	biomarker	biomarker	NOUN
gra-1903	63	10	and	and	CCONJ
gra-1903	63	11	as	as	ADP
gra-1903	63	12	a	a	DET
gra-1903	63	13	combination	combination	NOUN
gra-1903	63	14	with	with	ADP
gra-1903	63	15	other	other	ADJ
gra-1903	63	16	tumour	tumour	ADJ
gra-1903	63	17	markers	marker	NOUN
gra-1903	63	18	to	to	PART
gra-1903	63	19	suggest	suggest	VERB
gra-1903	63	20	the	the	DET
gra-1903	63	21	histological	histological	ADJ
gra-1903	63	22	diagnosis	diagnosis	NOUN
gra-1903	63	23	and	and	CCONJ
gra-1903	63	24	metastasis	metastasis	NOUN
gra-1903	63	25	risk	risk	NOUN
gra-1903	63	26	.	.	PUNCT
gra-1903	64	1	in	in	ADP
gra-1903	64	2	cases	case	NOUN
gra-1903	64	3	of	of	ADP
gra-1903	64	4	sclc	sclc	PROPN
gra-1903	64	5	,	,	PUNCT
gra-1903	64	6	serum	serum	PROPN
gra-1903	64	7	cea	cea	PROPN
gra-1903	64	8	estimation	estimation	NOUN
gra-1903	64	9	can	can	AUX
gra-1903	64	10	get	get	AUX
gra-1903	64	11	affected	affect	VERB
gra-1903	64	12	by	by	ADP
gra-1903	64	13	various	various	ADJ
gra-1903	64	14	factors	factor	NOUN
gra-1903	64	15	and	and	CCONJ
gra-1903	64	16	is	be	AUX
gra-1903	64	17	not	not	PART
gra-1903	64	18	being	be	AUX
gra-1903	64	19	used	use	VERB
gra-1903	64	20	as	as	ADP
gra-1903	64	21	an	an	DET
gra-1903	64	22	ideal	ideal	ADJ
gra-1903	64	23	marker	marker	NOUN
gra-1903	64	24	.	.	PUNCT
gra-1903	65	1	differentiation	differentiation	NOUN
gra-1903	65	2	and	and	CCONJ
gra-1903	65	3	staging	staging	NOUN
gra-1903	65	4	of	of	ADP
gra-1903	65	5	the	the	DET
gra-1903	65	6	different	different	ADJ
gra-1903	65	7	types	type	NOUN
gra-1903	65	8	of	of	ADP
gra-1903	65	9	lung	lung	NOUN
gra-1903	65	10	cancer	cancer	NOUN
gra-1903	65	11	based	base	VERB
gra-1903	65	12	on	on	ADP
gra-1903	65	13	serum	serum	PROPN
gra-1903	65	14	cea	cea	PROPN
gra-1903	65	15	levels	level	NOUN
gra-1903	65	16	varies	vary	VERB
gra-1903	65	17	greatly	greatly	ADV
gra-1903	65	18	as	as	SCONJ
gra-1903	65	19	serum	serum	PROPN
gra-1903	65	20	cea	cea	PROPN
gra-1903	65	21	levels	level	NOUN
gra-1903	65	22	get	get	AUX
gra-1903	65	23	affected	affect	VERB
gra-1903	65	24	by	by	ADP
gra-1903	65	25	various	various	ADJ
gra-1903	65	26	factors	factor	NOUN
gra-1903	65	27	such	such	ADJ
gra-1903	65	28	as	as	ADP
gra-1903	65	29	smoking	smoking	NOUN
gra-1903	65	30	volume-9	volume-9	NUM
gra-1903	65	31	,	,	PUNCT
gra-1903	65	32	issue-2	issue-2	PROPN
gra-1903	65	33	,	,	PUNCT
gra-1903	65	34	february-2020	february-2020	VERB
gra-1903	65	35	•	•	NUM
gra-1903	65	36	print	print	NOUN
gra-1903	65	37	issn	issn	PROPN
gra-1903	65	38	no	no	NOUN
gra-1903	65	39	.	.	PROPN
gra-1903	66	1	2277	2277	NUM
gra-1903	66	2	8160	8160	NUM
gra-1903	66	3	•	•	NOUN
gra-1903	66	4	doi	doi	NOUN
gra-1903	66	5	:	:	PUNCT
gra-1903	66	6	10.36106	10.36106	NUM
gra-1903	66	7	/	/	SYM
gra-1903	66	8	gjra	gjra	ADJ
gra-1903	66	9	squamous	squamous	ADJ
gra-1903	66	10	cell	cell	NOUN
gra-1903	66	11	carcinoma	carcinoma	NOUN
gra-1903	66	12	26	26	NUM
gra-1903	66	13	35.14	35.14	NUM
gra-1903	66	14	small	small	ADJ
gra-1903	66	15	cell	cell	NOUN
gra-1903	66	16	lung	lung	NOUN
gra-1903	66	17	carcinoma	carcinoma	NOUN
gra-1903	66	18	10	10	NUM
gra-1903	66	19	13.51	13.51	NUM
gra-1903	66	20	74	74	NUM
gra-1903	66	21	100.00	100.00	NUM
gra-1903	66	22	type	type	NOUN
gra-1903	66	23	cea	cea	PROPN
gra-1903	66	24	level	level	NOUN
gra-1903	66	25	total	total	ADJ
gra-1903	66	26	%	%	NOUN
gra-1903	66	27	of	of	ADP
gra-1903	66	28	patients	patient	NOUN
gra-1903	66	29	with	with	ADP
gra-1903	66	30	cea	cea	PROPN
gra-1903	66	31	level	level	NOUN
gra-1903	66	32	higher	high	ADJ
gra-1903	66	33	than	than	ADP
gra-1903	66	34	normal	normal	ADJ
gra-1903	66	35	no	no	NOUN
gra-1903	66	36	.	.	PUNCT
gra-1903	66	37	of	of	ADP
gra-1903	66	38	cases	case	NOUN
gra-1903	66	39	with	with	ADP
gra-1903	66	40	cea	cea	PROPN
gra-1903	66	41	<	<	X
gra-1903	66	42	4	4	NUM
gra-1903	66	43	ng	ng	NOUN
gra-1903	66	44	/	/	SYM
gra-1903	66	45	ml	ml	NOUN
gra-1903	66	46	no	no	NOUN
gra-1903	66	47	.	.	PUNCT
gra-1903	66	48	of	of	ADP
gra-1903	66	49	cases	case	NOUN
gra-1903	66	50	with	with	ADP
gra-1903	66	51	cea	cea	PROPN
gra-1903	66	52	>	>	PROPN
gra-1903	66	53	4	4	NUM
gra-1903	66	54	ng	ng	PROPN
gra-1903	66	55	/	/	SYM
gra-1903	66	56	ml	ml	PART
gra-1903	66	57	adenocarcinoma	adenocarcinoma	NOUN
gra-1903	66	58	11	11	NUM
gra-1903	66	59	27	27	NUM
gra-1903	66	60	38	38	NUM
gra-1903	66	61	71.05	71.05	NUM
gra-1903	66	62	small	small	ADJ
gra-1903	66	63	cell	cell	NOUN
gra-1903	66	64	lung	lung	NOUN
gra-1903	66	65	cancer	cancer	NOUN
gra-1903	66	66	4	4	NUM
gra-1903	66	67	6	6	NUM
gra-1903	66	68	10	10	NUM
gra-1903	66	69	60	60	NUM
gra-1903	66	70	squamous	squamous	ADJ
gra-1903	66	71	cell	cell	NOUN
gra-1903	66	72	carcinoma	carcinoma	NOUN
gra-1903	66	73	16	16	NUM
gra-1903	66	74	10	10	NUM
gra-1903	66	75	26	26	NUM
gra-1903	66	76	38.46	38.46	NUM
gra-1903	66	77	cea	cea	PROPN
gra-1903	66	78	level	level	PROPN
gra-1903	66	79	metastasis	metastasis	NOUN
gra-1903	66	80	total	total	ADJ
gra-1903	66	81	adrenal	adrenal	ADJ
gra-1903	66	82	bone	bone	NOUN
gra-1903	66	83	brain	brain	NOUN
gra-1903	66	84	liver	liver	NOUN
gra-1903	66	85	pleural	pleural	ADJ
gra-1903	66	86	multiple	multiple	ADJ
gra-1903	66	87	cea	cea	PROPN
gra-1903	66	88	level	level	NOUN
gra-1903	66	89	<	<	PROPN
gra-1903	66	90	4	4	NUM
gra-1903	66	91	ng	ng	NOUN
gra-1903	66	92	/	/	SYM
gra-1903	66	93	ml	ml	NOUN
gra-1903	66	94	4	4	NUM
gra-1903	66	95	3	3	NUM
gra-1903	66	96	1	1	NUM
gra-1903	66	97	2	2	NUM
gra-1903	66	98	0	0	NUM
gra-1903	66	99	2	2	NUM
gra-1903	66	100	12	12	NUM
gra-1903	66	101	cea	cea	PROPN
gra-1903	66	102	level	level	NOUN
gra-1903	66	103	>	>	PROPN
gra-1903	66	104	4	4	NUM
gra-1903	66	105	ng	ng	NOUN
gra-1903	66	106	/	/	SYM
gra-1903	66	107	ml	ml	PROPN
gra-1903	66	108	6	6	NUM
gra-1903	66	109	4	4	NUM
gra-1903	66	110	5	5	NUM
gra-1903	66	111	5	5	NUM
gra-1903	66	112	3	3	NUM
gra-1903	66	113	7	7	NUM
gra-1903	66	114	30	30	NUM
gra-1903	66	115	%	%	NOUN
gra-1903	66	116	of	of	ADP
gra-1903	66	117	patients	patient	NOUN
gra-1903	66	118	with	with	ADP
gra-1903	66	119	cea	cea	PROPN
gra-1903	66	120	level	level	NOUN
gra-1903	66	121	higher	high	ADJ
gra-1903	66	122	than	than	ADP
gra-1903	66	123	normal	normal	ADJ
gra-1903	66	124	60	60	NUM
gra-1903	66	125	57.14	57.14	NUM
gra-1903	66	126	83.33	83.33	NUM
gra-1903	66	127	71.43	71.43	NUM
gra-1903	66	128	100	100	NUM
gra-1903	66	129	77.78	77.78	NUM
gra-1903	66	130	71.43	71.43	NUM
gra-1903	66	131	stage	stage	NOUN
gra-1903	66	132	cea	cea	PROPN
gra-1903	66	133	level	level	NOUN
gra-1903	66	134	total	total	ADJ
gra-1903	66	135	%	%	NOUN
gra-1903	66	136	of	of	ADP
gra-1903	66	137	cases	case	NOUN
gra-1903	66	138	with	with	ADP
gra-1903	66	139	cea	cea	PROPN
gra-1903	66	140	level	level	NOUN
gra-1903	66	141	higher	high	ADJ
gra-1903	66	142	than	than	ADP
gra-1903	66	143	normal	normal	ADJ
gra-1903	66	144	no	no	NOUN
gra-1903	66	145	.	.	PUNCT
gra-1903	66	146	of	of	ADP
gra-1903	66	147	cases	case	NOUN
gra-1903	66	148	with	with	ADP
gra-1903	66	149	cea	cea	PROPN
gra-1903	66	150	<	<	X
gra-1903	66	151	4	4	NUM
gra-1903	66	152	ng	ng	NOUN
gra-1903	66	153	/	/	SYM
gra-1903	66	154	ml	ml	NOUN
gra-1903	66	155	no	no	NOUN
gra-1903	66	156	.	.	PUNCT
gra-1903	66	157	of	of	ADP
gra-1903	66	158	cases	case	NOUN
gra-1903	66	159	with	with	ADP
gra-1903	66	160	cea	cea	PROPN
gra-1903	66	161	>	>	PROPN
gra-1903	66	162	4	4	NUM
gra-1903	66	163	ng	ng	PROPN
gra-1903	66	164	/	/	SYM
gra-1903	66	165	ml	ml	NOUN
gra-1903	66	166	ia	ia	PROPN
gra-1903	66	167	2	2	NUM
gra-1903	66	168	0	0	NUM
gra-1903	66	169	2	2	NUM
gra-1903	66	170	0	0	NUM
gra-1903	66	171	ib	ib	NOUN
gra-1903	66	172	3	3	NUM
gra-1903	66	173	0	0	NUM
gra-1903	66	174	3	3	NUM
gra-1903	66	175	0	0	NUM
gra-1903	66	176	iia	iia	VERB
gra-1903	66	177	5	5	NUM
gra-1903	66	178	2	2	NUM
gra-1903	66	179	7	7	NUM
gra-1903	66	180	28.57	28.57	NUM
gra-1903	66	181	iib	iib	NOUN
gra-1903	66	182	5	5	NUM
gra-1903	66	183	2	2	NUM
gra-1903	66	184	7	7	NUM
gra-1903	66	185	28.57	28.57	NUM
gra-1903	66	186	iiia	iiia	ADP
gra-1903	66	187	3	3	NUM
gra-1903	66	188	4	4	NUM
gra-1903	66	189	7	7	NUM
gra-1903	66	190	57.14	57.14	NUM
gra-1903	66	191	iiib	iiib	NOUN
gra-1903	66	192	0	0	NUM
gra-1903	66	193	5	5	NUM
gra-1903	66	194	5	5	NUM
gra-1903	66	195	100	100	NUM
gra-1903	66	196	iv	iv	NUM
gra-1903	66	197	12	12	NUM
gra-1903	66	198	30	30	NUM
gra-1903	66	199	42	42	NUM
gra-1903	66	200	71.43	71.43	NUM
gra-1903	66	201	etc	etc	X
gra-1903	66	202	.	.	X
gra-1903	67	1	hence	hence	ADV
gra-1903	67	2	serum	serum	PROPN
gra-1903	67	3	cea	cea	PROPN
gra-1903	67	4	level	level	NOUN
gra-1903	67	5	estimation	estimation	NOUN
gra-1903	67	6	can	can	AUX
gra-1903	67	7	be	be	AUX
gra-1903	67	8	considered	consider	VERB
gra-1903	67	9	as	as	ADP
gra-1903	67	10	a	a	DET
gra-1903	67	11	tool	tool	NOUN
gra-1903	67	12	for	for	ADP
gra-1903	67	13	prognosis	prognosis	NOUN
gra-1903	67	14	and	and	CCONJ
gra-1903	67	15	grading	grade	VERB
gra-1903	67	16	than	than	ADP
gra-1903	67	17	as	as	ADP
gra-1903	67	18	a	a	DET
gra-1903	67	19	marker	marker	NOUN
gra-1903	67	20	for	for	ADP
gra-1903	67	21	predicting	predict	VERB
gra-1903	67	22	the	the	DET
gra-1903	67	23	nature	nature	NOUN
gra-1903	67	24	of	of	ADP
gra-1903	67	25	the	the	DET
gra-1903	67	26	disease	disease	NOUN
gra-1903	67	27	.	.	PUNCT
gra-1903	68	1	references	reference	NOUN
gra-1903	68	2	1	1	NUM
gra-1903	68	3	.	.	PUNCT
gra-1903	68	4	beasley	beasley	PROPN
gra-1903	68	5	mb	mb	PROPN
gra-1903	68	6	,	,	PUNCT
gra-1903	68	7	brambilla	brambilla	NOUN
gra-1903	68	8	e	e	NOUN
gra-1903	68	9	,	,	PUNCT
gra-1903	68	10	travis	travis	PROPN
gra-1903	68	11	wd	wd	PROPN
gra-1903	68	12	.	.	PUNCT
gra-1903	69	1	the	the	DET
gra-1903	69	2	2004	2004	NUM
gra-1903	69	3	world	world	PROPN
gra-1903	69	4	health	health	NOUN
gra-1903	69	5	organization	organization	NOUN
gra-1903	69	6	classication	classication	NOUN
gra-1903	69	7	of	of	ADP
gra-1903	69	8	lung	lung	NOUN
gra-1903	69	9	tumors	tumor	NOUN
gra-1903	69	10	.	.	PUNCT
gra-1903	70	1	seminroentgenol	seminroentgenol	PROPN
gra-1903	70	2	2005;40:90	2005;40:90	NUM
gra-1903	70	3	-	-	SYM
gra-1903	70	4	7	7	NUM
gra-1903	70	5	.	.	NOUN
gra-1903	70	6	2	2	NUM
gra-1903	70	7	.	.	NOUN
gra-1903	70	8	pamies	pamie	NOUN
gra-1903	70	9	,	,	PUNCT
gra-1903	70	10	r.j	r.j	PROPN
gra-1903	70	11	.	.	PROPN
gra-1903	70	12	and	and	CCONJ
gra-1903	70	13	crawford	crawford	PROPN
gra-1903	70	14	,	,	PUNCT
gra-1903	70	15	d.r	d.r	PROPN
gra-1903	70	16	.	.	PROPN
gra-1903	70	17	(	(	PUNCT
gra-1903	70	18	1996	1996	NUM
gra-1903	70	19	)	)	PUNCT
gra-1903	70	20	.	.	PUNCT
gra-1903	71	1	tumour	tumour	NOUN
gra-1903	71	2	markers	marker	NOUN
gra-1903	71	3	:	:	PUNCT
gra-1903	71	4	an	an	DET
gra-1903	71	5	update	update	NOUN
gra-1903	71	6	med	me	VERB
gra-1903	71	7	.	.	PUNCT
gra-1903	72	1	clin	clin	PROPN
gra-1903	72	2	.	.	PUNCT
gra-1903	73	1	north	north	PROPN
gra-1903	73	2	am	am	PROPN
gra-1903	73	3	.	.	PUNCT
gra-1903	74	1	80,185	80,185	NUM
gra-1903	74	2	-	-	SYM
gra-1903	74	3	199	199	NUM
gra-1903	74	4	.	.	PUNCT
gra-1903	75	1	3	3	X
gra-1903	75	2	.	.	X
gra-1903	75	3	gold	gold	NOUN
gra-1903	75	4	p	p	NOUN
gra-1903	75	5	,	,	PUNCT
gra-1903	75	6	freedman	freedman	PROPN
gra-1903	75	7	so	so	ADV
gra-1903	75	8	.	.	PUNCT
gra-1903	76	1	demonstration	demonstration	NOUN
gra-1903	76	2	of	of	ADP
gra-1903	76	3	tumour	tumour	NOUN
gra-1903	76	4	-	-	PUNCT
gra-1903	76	5	specic	specic	NOUN
gra-1903	76	6	antigens	antigen	NOUN
gra-1903	76	7	in	in	ADP
gra-1903	76	8	human	human	ADJ
gra-1903	76	9	colonic	colonic	NOUN
gra-1903	76	10	carcinomata	carcinomata	NOUN
gra-1903	76	11	by	by	ADP
gra-1903	76	12	immunological	immunological	ADJ
gra-1903	76	13	tolerance	tolerance	NOUN
gra-1903	76	14	and	and	CCONJ
gra-1903	76	15	absorption	absorption	NOUN
gra-1903	76	16	techniques	technique	NOUN
gra-1903	76	17	.	.	PUNCT
gra-1903	77	1	j	j	PROPN
gra-1903	77	2	exp	exp	NOUN
gra-1903	77	3	med	med	PROPN
gra-1903	77	4	1965	1965	NUM
gra-1903	77	5	mar	mar	PROPN
gra-1903	77	6	1;121:439–462	1;121:439–462	NUM
gra-1903	77	7	4	4	NUM
gra-1903	77	8	.	.	PUNCT
gra-1903	77	9	buccheri	buccheri	NOUN
gra-1903	77	10	and	and	CCONJ
gra-1903	77	11	ferrigno	ferrigno	PROPN
gra-1903	77	12	et	et	PROPN
gra-1903	77	13	al	al	PROPN
gra-1903	77	14	,	,	PUNCT
gra-1903	77	15	identifying	identify	VERB
gra-1903	77	16	patients	patient	NOUN
gra-1903	77	17	at	at	ADP
gra-1903	77	18	risk	risk	NOUN
gra-1903	77	19	of	of	ADP
gra-1903	77	20	early	early	ADJ
gra-1903	77	21	postoperativerecurrence	postoperativerecurrence	NOUN
gra-1903	77	22	of	of	ADP
gra-1903	77	23	lung	lung	NOUN
gra-1903	77	24	cancer	cancer	NOUN
gra-1903	77	25	:	:	PUNCT
gra-1903	77	26	a	a	DET
gra-1903	77	27	new	new	ADJ
gra-1903	77	28	use	use	NOUN
gra-1903	77	29	of	of	ADP
gra-1903	77	30	the	the	DET
gra-1903	77	31	old	old	ADJ
gra-1903	77	32	ceatest	ceat	ADJ
gra-1903	77	33	annthoracsurg	annthoracsurg	NOUN
gra-1903	77	34	2003;75:973–80	2003;75:973–80	PROPN
gra-1903	77	35	5	5	NUM
gra-1903	77	36	.	.	NUM
gra-1903	77	37	stevens	stevens	PROPN
gra-1903	77	38	dp	dp	PROPN
gra-1903	77	39	,	,	PUNCT
gra-1903	77	40	mackay	mackay	PROPN
gra-1903	77	41	ir	ir	AUX
gra-1903	77	42	.	.	PROPN
gra-1903	77	43	increased	increase	VERB
gra-1903	77	44	carcinoembryonic	carcinoembryonic	ADJ
gra-1903	77	45	antigen	antigen	NOUN
gra-1903	77	46	in	in	ADP
gra-1903	77	47	heavy	heavy	ADJ
gra-1903	77	48	cigarette	cigarette	NOUN
gra-1903	77	49	smokers	smoker	NOUN
gra-1903	77	50	.	.	PUNCT
gra-1903	78	1	lancet	lancet	PROPN
gra-1903	78	2	1973;2:1238–9	1973;2:1238–9	NUM
gra-1903	78	3	.	.	PUNCT
gra-1903	79	1	6	6	NUM
gra-1903	79	2	.	.	X
gra-1903	79	3	oscar	oscar	PROPN
gra-1903	79	4	arrieta	arrieta	PROPN
gra-1903	79	5	,	,	PUNCT
gra-1903	79	6	cynthia	cynthia	PROPN
gra-1903	79	7	villarreal	villarreal	PROPN
gra-1903	79	8	garza	garza	PROPN
gra-1903	79	9	et	et	PROPN
gra-1903	79	10	al	al	PROPN
gra-1903	79	11	,	,	PUNCT
gra-1903	79	12	usefulness	usefulness	NOUN
gra-1903	79	13	of	of	ADP
gra-1903	79	14	serum	serum	NOUN
gra-1903	79	15	carcinoembryonic	carcinoembryonic	ADJ
gra-1903	79	16	antigen(cea	antigen(cea	NOUN
gra-1903	79	17	)	)	PUNCT
gra-1903	79	18	in	in	ADP
gra-1903	79	19	evaluating	evaluate	VERB
gra-1903	79	20	response	response	NOUN
gra-1903	79	21	to	to	ADP
gra-1903	79	22	chemotherapy	chemotherapy	NOUN
gra-1903	79	23	in	in	ADP
gra-1903	79	24	patients	patient	NOUN
gra-1903	79	25	with	with	ADP
gra-1903	79	26	advanced	advanced	ADJ
gra-1903	79	27	non	non	ADJ
gra-1903	79	28	small	small	ADJ
gra-1903	79	29	-	-	PUNCT
gra-1903	79	30	cell	cell	NOUN
gra-1903	79	31	lung	lung	NOUN
gra-1903	79	32	cancer	cancer	NOUN
gra-1903	79	33	:	:	PUNCT
gra-1903	79	34	a	a	DET
gra-1903	79	35	prospective	prospective	ADJ
gra-1903	79	36	cohort	cohort	NOUN
gra-1903	79	37	study	study	NOUN
gra-1903	79	38	,	,	PUNCT
gra-1903	79	39	bmc	bmc	ADJ
gra-1903	79	40	cancer	cancer	NOUN
gra-1903	79	41	2013	2013	NUM
gra-1903	79	42	,	,	PUNCT
gra-1903	79	43	13:254	13:254	NUM
gra-1903	79	44	7	7	NUM
gra-1903	79	45	.	.	PUNCT
gra-1903	80	1	konstantinos	konstantino	NOUN
gra-1903	80	2	charalabopoulos,1	charalabopoulos,1	PROPN
gra-1903	80	3	agathikarakosta	agathikarakosta	PROPN
gra-1903	80	4	et	et	PROPN
gra-1903	80	5	al	al	PROPN
gra-1903	80	6	cea	cea	PROPN
gra-1903	80	7	levels	level	NOUN
gra-1903	80	8	in	in	ADP
gra-1903	80	9	serum	serum	NOUN
gra-1903	80	10	and	and	CCONJ
gra-1903	80	11	bal	bal	PROPN
gra-1903	80	12	in	in	ADP
gra-1903	80	13	patients	patient	NOUN
gra-1903	80	14	suffering	suffer	VERB
gra-1903	80	15	from	from	ADP
gra-1903	80	16	lung	lung	NOUN
gra-1903	80	17	cancer	cancer	NOUN
gra-1903	80	18	correlation	correlation	NOUN
gra-1903	80	19	with	with	ADP
gra-1903	80	20	individuals	individual	NOUN
gra-1903	80	21	presenting	present	VERB
gra-1903	80	22	benign	benign	ADJ
gra-1903	80	23	lung	lung	NOUN
gra-1903	80	24	lesions	lesion	NOUN
gra-1903	80	25	and	and	CCONJ
gra-1903	80	26	healthy	healthy	ADJ
gra-1903	80	27	volunteers	volunteer	NOUN
gra-1903	80	28	,	,	PUNCT
gra-1903	80	29	medical	medical	ADJ
gra-1903	80	30	oncology	oncology	NOUN
gra-1903	80	31	,	,	PUNCT
gra-1903	80	32	vol	vol	NOUN
gra-1903	80	33	.	.	PROPN
gra-1903	81	1	24	24	NUM
gra-1903	81	2	,	,	PUNCT
gra-1903	81	3	no	no	INTJ
gra-1903	81	4	.	.	NOUN
gra-1903	81	5	2	2	NUM
gra-1903	81	6	,	,	PUNCT
gra-1903	81	7	219–225	219–225	NUM
gra-1903	81	8	,	,	PUNCT
gra-1903	81	9	2007	2007	NUM
gra-1903	81	10	8	8	NUM
gra-1903	81	11	.	.	PUNCT
gra-1903	82	1	jae	jae	PROPN
gra-1903	82	2	jun	jun	PROPN
gra-1903	82	3	kim	kim	PROPN
gra-1903	82	4	,	,	PUNCT
gra-1903	82	5	m.d.1	m.d.1	PROPN
gra-1903	82	6	,	,	PUNCT
gra-1903	82	7	kwanyonghyun	kwanyonghyun	NOUN
gra-1903	82	8	,	,	PUNCT
gra-1903	82	9	the	the	DET
gra-1903	82	10	signicance	signicance	NOUN
gra-1903	82	11	of	of	ADP
gra-1903	82	12	serum	serum	NOUN
gra-1903	82	13	carcinoembryonic	carcinoembryonic	ADJ
gra-1903	82	14	antigen	antigen	NOUN
gra-1903	82	15	in	in	ADP
gra-1903	82	16	lung	lung	NOUN
gra-1903	82	17	adenocarcinoma	adenocarcinoma	NOUN
gra-1903	82	18	,	,	PUNCT
gra-1903	82	19	korean	korean	PROPN
gra-1903	82	20	j	j	PROPN
gra-1903	82	21	thorac	thorac	PROPN
gra-1903	82	22	cardiovasc	cardiovasc	PROPN
gra-1903	82	23	surg	surg	PROPN
gra-1903	82	24	2015;48:335	2015;48:335	PROPN
gra-1903	82	25	-	-	NUM
gra-1903	82	26	344	344	NUM
gra-1903	82	27	9	9	NUM
gra-1903	82	28	.	.	PUNCT
gra-1903	83	1	feng	feng	PROPN
gra-1903	83	2	chen	chen	PROPN
gra-1903	83	3	,	,	PUNCT
gra-1903	83	4	jia	jia	PROPN
gra-1903	83	5	li	li	PROPN
gra-1903	83	6	,	,	PUNCT
gra-1903	83	7	diagnostic	diagnostic	ADJ
gra-1903	83	8	value	value	NOUN
gra-1903	83	9	of	of	ADP
gra-1903	83	10	cyfra	cyfra	NOUN
gra-1903	83	11	21	21	NUM
gra-1903	83	12	-	-	SYM
gra-1903	83	13	1	1	NUM
gra-1903	83	14	and	and	CCONJ
gra-1903	83	15	carcinoembryonic	carcinoembryonic	ADJ
gra-1903	83	16	antigen	antigen	NOUN
gra-1903	83	17	in	in	ADP
gra-1903	83	18	diagnosis	diagnosis	NOUN
gra-1903	83	19	of	of	ADP
gra-1903	83	20	operable	operable	ADJ
gra-1903	83	21	lung	lung	NOUN
gra-1903	83	22	cancer	cancer	NOUN
gra-1903	83	23	from	from	ADP
gra-1903	83	24	benign	benign	ADJ
gra-1903	83	25	lung	lung	NOUN
gra-1903	83	26	disease	disease	NOUN
gra-1903	83	27	,	,	PUNCT
gra-1903	83	28	journal	journal	NOUN
gra-1903	83	29	of	of	ADP
gra-1903	83	30	cancer	cancer	NOUN
gra-1903	83	31	research	research	NOUN
gra-1903	83	32	and	and	CCONJ
gra-1903	83	33	therapeutics	therapeutic	NOUN
gra-1903	83	34	–	–	PUNCT
gra-1903	83	35	vol.14	vol.14	NOUN
gra-1903	83	36	(	(	PUNCT
gra-1903	83	37	2);2018	2);2018	NUM
gra-1903	83	38	10	10	NUM
gra-1903	83	39	.	.	PUNCT
gra-1903	84	1	zaleska	zaleska	PROPN
gra-1903	84	2	m	m	PROPN
gra-1903	84	3	,	,	PUNCT
gra-1903	84	4	szturmowicz	szturmowicz	PROPN
gra-1903	84	5	m	m	PROPN
gra-1903	84	6	,	,	PUNCT
gra-1903	84	7	zych	zych	PROPN
gra-1903	84	8	j	j	PROPN
gra-1903	84	9	,	,	PUNCT
gra-1903	84	10	sliz	sliz	NOUN
gra-1903	84	11	b	b	NOUN
gra-1903	84	12	,	,	PUNCT
gra-1903	84	13	demkow	demkow	PROPN
gra-1903	84	14	u	u	NOUN
gra-1903	84	15	,	,	PUNCT
gra-1903	84	16	langfort	langfort	NOUN
gra-1903	84	17	r	r	NOUN
gra-1903	84	18	,	,	PUNCT
gra-1903	84	19	et	et	PROPN
gra-1903	84	20	al	al	PROPN
gra-1903	84	21	.	.	PROPN
gra-1903	84	22	elevatedserum	elevatedserum	PROPN
gra-1903	84	23	nse	nse	NOUN
gra-1903	84	24	in	in	ADP
gra-1903	84	25	inoperable	inoperable	ADJ
gra-1903	84	26	non	non	ADJ
gra-1903	84	27	-	-	ADJ
gra-1903	84	28	small	small	ADJ
gra-1903	84	29	-	-	PUNCT
gra-1903	84	30	cell	cell	NOUN
gra-1903	84	31	lung	lung	NOUN
gra-1903	84	32	carcinoma	carcinoma	NOUN
gra-1903	84	33	(	(	PUNCT
gra-1903	84	34	nsclc	nsclc	NOUN
gra-1903	84	35	)	)	PUNCT
gra-1903	84	36	is	be	AUX
gra-1903	84	37	associated	associate	VERB
gra-1903	84	38	with	with	ADP
gra-1903	84	39	a	a	DET
gra-1903	84	40	better	well	ADJ
gra-1903	84	41	response	response	NOUN
gra-1903	84	42	but	but	CCONJ
gra-1903	84	43	worse	bad	ADJ
gra-1903	84	44	prognosis	prognosis	NOUN
gra-1903	84	45	.	.	PUNCT
gra-1903	85	1	pneumonolalergol	pneumonolalergol	NOUN
gra-1903	85	2	pol2010;78(1):14–20	pol2010;78(1):14–20	NOUN
gra-1903	85	3	11	11	NUM
gra-1903	85	4	.	.	PUNCT
gra-1903	86	1	aoyagi	aoyagi	PROPN
gra-1903	86	2	k	k	PROPN
gra-1903	86	3	,	,	PUNCT
gra-1903	86	4	miyake	miyake	PROPN
gra-1903	86	5	y	y	PROPN
gra-1903	86	6	,	,	PUNCT
gra-1903	86	7	urakami	urakami	ADJ
gra-1903	86	8	k	k	PROPN
gra-1903	86	9	,	,	PUNCT
gra-1903	86	10	kashiwakuma	kashiwakuma	PROPN
gra-1903	86	11	t	t	PROPN
gra-1903	86	12	,	,	PUNCT
gra-1903	86	13	hasegawa	hasegawa	PROPN
gra-1903	86	14	a	a	PROPN
gra-1903	86	15	,	,	PUNCT
gra-1903	86	16	kodoma	kodoma	NOUN
gra-1903	86	17	t	t	PROPN
gra-1903	86	18	,	,	PUNCT
gra-1903	86	19	et	et	PROPN
gra-1903	86	20	al	al	PROPN
gra-1903	86	21	:	:	PUNCT
gra-1903	86	22	enzyme	enzyme	NOUN
gra-1903	86	23	immunoassay	immunoassay	NOUN
gra-1903	86	24	of	of	ADP
gra-1903	86	25	immunoreactive	immunoreactive	ADJ
gra-1903	86	26	progastrinreleasing	progastrinrelease	VERB
gra-1903	86	27	peptide(31–98	peptide(31–98	PROPN
gra-1903	86	28	)	)	PUNCT
gra-1903	86	29	as	as	ADP
gra-1903	86	30	tumor	tumor	NOUN
gra-1903	86	31	marker	marker	NOUN
gra-1903	86	32	for	for	ADP
gra-1903	86	33	small	small	ADJ
gra-1903	86	34	cell	cell	NOUN
gra-1903	86	35	lung	lung	NOUN
gra-1903	86	36	carcinoma	carcinoma	NOUN
gra-1903	86	37	:	:	PUNCT
gra-1903	86	38	development	development	NOUN
gra-1903	86	39	and	and	CCONJ
gra-1903	86	40	evaluation	evaluation	NOUN
gra-1903	86	41	.	.	PUNCT
gra-1903	87	1	clinchem	clinchem	PROPN
gra-1903	88	1	1995;41	1995;41	NUM
gra-1903	88	2	:	:	PUNCT
gra-1903	89	1	537–543	537–543	NUM
gra-1903	89	2	12	12	NUM
gra-1903	89	3	.	.	PUNCT
gra-1903	90	1	ahmet	ahmet	PROPN
gra-1903	90	2	ursavas	ursavas	PROPN
gra-1903	90	3	,	,	PUNCT
gra-1903	90	4	mehmet	mehmet	PROPN
gra-1903	90	5	karadag	karadag	PROPN
gra-1903	90	6	et	et	PROPN
gra-1903	90	7	al	al	PROPN
gra-1903	90	8	serum	serum	PROPN
gra-1903	90	9	carcinoembryonicantigen	carcinoembryonicantigen	NOUN
gra-1903	90	10	level	level	NOUN
gra-1903	90	11	as	as	ADP
gra-1903	90	12	a	a	DET
gra-1903	90	13	predictive	predictive	ADJ
gra-1903	90	14	marker	marker	NOUN
gra-1903	90	15	for	for	ADP
gra-1903	90	16	distant	distant	ADJ
gra-1903	90	17	metastasis	metastasis	NOUN
gra-1903	90	18	in	in	ADP
gra-1903	90	19	non	non	ADJ
gra-1903	90	20	-	-	ADJ
gra-1903	90	21	small	small	ADJ
gra-1903	90	22	cell	cell	NOUN
gra-1903	90	23	lung	lung	NOUN
gra-1903	90	24	cancer	cancer	NOUN
gra-1903	90	25	,	,	PUNCT
gra-1903	90	26	eur	eur	PROPN
gra-1903	90	27	j	j	PROPN
gra-1903	90	28	gen	gen	PROPN
gra-1903	90	29	med	me	VERB
gra-1903	90	30	2007;4(3):107	2007;4(3):107	PROPN
gra-1903	90	31	-	-	SYM
gra-1903	90	32	114	114	NUM
gra-1903	90	33	13	13	NUM
gra-1903	90	34	.	.	PUNCT
gra-1903	91	1	arrieta	arrieta	PROPN
gra-1903	91	2	o	o	PROPN
gra-1903	91	3	,	,	PUNCT
gra-1903	91	4	saavedra	saavedra	PROPN
gra-1903	91	5	-	-	PUNCT
gra-1903	91	6	perez	perez	PROPN
gra-1903	91	7	d	d	PROPN
gra-1903	91	8	,	,	PUNCT
gra-1903	91	9	kuri	kuri	PROPN
gra-1903	91	10	r	r	PROPN
gra-1903	91	11	,	,	PUNCT
gra-1903	91	12	aviles	aviles	PROPN
gra-1903	91	13	-	-	PUNCT
gra-1903	91	14	salas	salas	PROPN
gra-1903	91	15	a	a	X
gra-1903	91	16	,	,	PUNCT
gra-1903	91	17	martinez	martinez	PROPN
gra-1903	91	18	l	l	PROPN
gra-1903	91	19	,	,	PUNCT
gra-1903	92	1	mendozaposada	mendozaposada	PROPN
gra-1903	92	2	d	d	PROPN
gra-1903	92	3	,	,	PUNCT
gra-1903	92	4	castillo	castillo	PROPN
gra-1903	92	5	p	p	X
gra-1903	92	6	,	,	PUNCT
gra-1903	92	7	astorga	astorga	VERB
gra-1903	92	8	a	a	PRON
gra-1903	92	9	,	,	PUNCT
gra-1903	92	10	guzman	guzman	PROPN
gra-1903	92	11	e	e	PROPN
gra-1903	92	12	,	,	PUNCT
gra-1903	92	13	de	de	X
gra-1903	92	14	la	la	PROPN
gra-1903	92	15	garza	garza	PROPN
gra-1903	92	16	j.	j.	PROPN
gra-1903	92	17	brain	brain	PROPN
gra-1903	92	18	metastasis	metastasis	NOUN
gra-1903	92	19	development	development	NOUN
gra-1903	92	20	and	and	CCONJ
gra-1903	92	21	poor	poor	ADJ
gra-1903	92	22	survival	survival	NOUN
gra-1903	92	23	associated	associate	VERB
gra-1903	92	24	with	with	ADP
gra-1903	92	25	carcinoembryonic	carcinoembryonic	ADJ
gra-1903	92	26	antigen	antigen	NOUN
gra-1903	92	27	(	(	PUNCT
gra-1903	92	28	cea	cea	PROPN
gra-1903	92	29	)	)	PUNCT
gra-1903	92	30	level	level	NOUN
gra-1903	92	31	in	in	ADP
gra-1903	92	32	advanced	advanced	ADJ
gra-1903	92	33	non	non	ADJ
gra-1903	92	34	-	-	ADJ
gra-1903	92	35	small	small	ADJ
gra-1903	92	36	cell	cell	NOUN
gra-1903	92	37	lung	lung	NOUN
gra-1903	92	38	cancer	cancer	NOUN
gra-1903	92	39	:	:	PUNCT
gra-1903	92	40	a	a	DET
gra-1903	92	41	prospective	prospective	ADJ
gra-1903	92	42	analysis	analysis	NOUN
gra-1903	92	43	.	.	PUNCT
gra-1903	93	1	bmc	bmc	ADJ
gra-1903	93	2	cancer	cancer	NOUN
gra-1903	93	3	.	.	PUNCT
gra-1903	94	1	2009	2009	NUM
gra-1903	94	2	dec;9(1):119	dec;9(1):119	PROPN
gra-1903	94	3	14	14	NUM
gra-1903	94	4	.	.	PUNCT
gra-1903	94	5	concannon	concannon	PROPN
gra-1903	94	6	jp	jp	PROPN
gra-1903	94	7	,	,	PUNCT
gra-1903	94	8	dalbow	dalbow	VERB
gra-1903	94	9	mh	mh	PROPN
gra-1903	94	10	,	,	PUNCT
gra-1903	94	11	hodgson	hodgson	PROPN
gra-1903	94	12	se	se	PROPN
gra-1903	94	13	,	,	PUNCT
gra-1903	94	14	et	et	PROPN
gra-1903	94	15	al	al	PROPN
gra-1903	94	16	.	.	PROPN
gra-1903	95	1	prognostic	prognostic	ADJ
gra-1903	95	2	value	value	NOUN
gra-1903	95	3	of	of	ADP
gra-1903	95	4	preoperative	preoperative	ADJ
gra-1903	95	5	carcinoembryonic	carcinoembryonic	ADJ
gra-1903	95	6	antigen	antigen	NOUN
gra-1903	95	7	(	(	PUNCT
gra-1903	95	8	cea	cea	PROPN
gra-1903	95	9	)	)	PUNCT
gra-1903	95	10	in	in	ADP
gra-1903	95	11	patients	patient	NOUN
gra-1903	95	12	with	with	ADP
gra-1903	95	13	bronchogenic	bronchogenic	ADJ
gra-1903	95	14	carcinoma	carcinoma	NOUN
gra-1903	95	15	.	.	PUNCT
gra-1903	96	1	cancer	cancer	NOUN
gra-1903	96	2	1978;42:1477	1978;42:1477	PROPN
gra-1903	96	3	-	-	SYM
gra-1903	96	4	83	83	NUM
gra-1903	96	5	15	15	NUM
gra-1903	96	6	.	.	PUNCT
gra-1903	97	1	yuan	yuan	PROPN
gra-1903	97	2	gao	gao	PROPN
gra-1903	97	3	,	,	PUNCT
gra-1903	97	4	pingping	pingping	NOUN
gra-1903	97	5	song	song	NOUN
gra-1903	97	6	et	et	PROPN
gra-1903	97	7	al	al	PROPN
gra-1903	97	8	,	,	PUNCT
gra-1903	97	9	elevated	elevate	VERB
gra-1903	97	10	serum	serum	PROPN
gra-1903	97	11	cea	cea	PROPN
gra-1903	97	12	levels	level	NOUN
gra-1903	97	13	are	be	AUX
gra-1903	97	14	associated	associate	VERB
gra-1903	97	15	with	with	ADP
gra-1903	97	16	the	the	DET
gra-1903	97	17	explosive	explosive	ADJ
gra-1903	97	18	progression	progression	NOUN
gra-1903	97	19	of	of	ADP
gra-1903	97	20	lung	lung	NOUN
gra-1903	97	21	adenocarcinoma	adenocarcinoma	NOUN
gra-1903	97	22	harboring	harboring	NOUN
gra-1903	97	23	egfr	egfr	ADJ
gra-1903	97	24	mutations	mutation	NOUN
gra-1903	97	25	,	,	PUNCT
gra-1903	97	26	gao	gao	PROPN
gra-1903	97	27	et	et	PROPN
gra-1903	97	28	al	al	PROPN
gra-1903	97	29	bmc	bmc	PROPN
gra-1903	97	30	cancer,2017,17:484	cancer,2017,17:484	PROPN
gra-1903	97	31	16	16	NUM
gra-1903	97	32	.	.	PUNCT
gra-1903	98	1	jiasi	jiasi	PROPN
gra-1903	98	2	wang	wang	PROPN
gra-1903	98	3	,	,	PUNCT
gra-1903	98	4	yanpeng	yanpeng	PROPN
gra-1903	98	5	chu	chu	PROPN
gra-1903	98	6	et	et	PROPN
gra-1903	98	7	al	al	PROPN
gra-1903	98	8	,	,	PUNCT
gra-1903	98	9	the	the	DET
gra-1903	98	10	clinical	clinical	ADJ
gra-1903	98	11	value	value	NOUN
gra-1903	98	12	of	of	ADP
gra-1903	98	13	carcinoembryonic	carcinoembryonic	ADJ
gra-1903	98	14	antigen	antigen	NOUN
gra-1903	98	15	for	for	ADP
gra-1903	98	16	tumor	tumor	NOUN
gra-1903	98	17	metastasis	metastasis	NOUN
gra-1903	98	18	assessment	assessment	NOUN
gra-1903	98	19	in	in	ADP
gra-1903	98	20	lung	lung	PROPN
gra-1903	98	21	cancer,2019,peerj	cancer,2019,peerj	NOUN
gra-1903	98	22	7	7	NUM
gra-1903	98	23	:	:	PUNCT
gra-1903	98	24	e7433	e7433	NUM
gra-1903	98	25	17	17	NUM
gra-1903	98	26	.	.	PUNCT
gra-1903	99	1	reck	reck	PROPN
gra-1903	99	2	m	m	PROPN
gra-1903	99	3	,	,	PUNCT
gra-1903	99	4	popat	popat	PROPN
gra-1903	99	5	s	s	PROPN
gra-1903	99	6	et	et	PROPN
gra-1903	99	7	al	al	PROPN
gra-1903	99	8	,	,	PUNCT
gra-1903	99	9	metastatic	metastatic	ADJ
gra-1903	99	10	non	non	ADJ
gra-1903	99	11	-	-	ADJ
gra-1903	99	12	small	small	ADJ
gra-1903	99	13	cell	cell	NOUN
gra-1903	99	14	lung	lung	NOUN
gra-1903	99	15	cancer(ns	cancer(ns	ADJ
gra-1903	99	16	clc	clc	PROPN
gra-1903	99	17	)	)	PUNCT
gra-1903	99	18	:	:	PUNCT
gra-1903	99	19	esmoclinical	esmoclinical	ADJ
gra-1903	99	20	practice	practice	NOUN
gra-1903	99	21	guidelines	guideline	NOUN
gra-1903	99	22	for	for	ADP
gra-1903	99	23	diagnosis	diagnosis	NOUN
gra-1903	99	24	,	,	PUNCT
gra-1903	99	25	treatment	treatment	NOUN
gra-1903	99	26	and	and	CCONJ
gra-1903	99	27	follow	follow	VERB
gra-1903	99	28	up	up	ADP
gra-1903	99	29	.	.	PUNCT
gra-1903	100	1	annals	annal	NOUN
gra-1903	100	2	of	of	ADP
gra-1903	100	3	oncology	oncology	NOUN
gra-1903	100	4	25(suppl	25(suppl	NUM
gra-1903	100	5	3):iii27	3):iii27	NUM
gra-1903	100	6	-	-	PUNCT
gra-1903	100	7	iii39	iii39	NOUN
gra-1903	100	8	x	x	PUNCT
gra-1903	100	9	61gjra	61gjra	PROPN
gra-1903	100	10	global	global	ADJ
gra-1903	100	11	journal	journal	PROPN
gra-1903	100	12	for	for	ADP
gra-1903	100	13	research	research	NOUN
gra-1903	100	14	analysis	analysis	NOUN
gra-1903	100	15	volume-9	volume-9	NUM
gra-1903	100	16	,	,	PUNCT
gra-1903	100	17	issue-2	issue-2	PROPN
gra-1903	100	18	,	,	PUNCT
gra-1903	100	19	february-2020	february-2020	VERB
gra-1903	100	20	•	•	NUM
gra-1903	100	21	print	print	NOUN
gra-1903	100	22	issn	issn	PROPN
gra-1903	100	23	no	no	NOUN
gra-1903	100	24	.	.	PROPN
gra-1903	101	1	2277	2277	NUM
gra-1903	101	2	8160	8160	NUM
gra-1903	101	3	•	•	NOUN
gra-1903	101	4	doi	doi	NOUN
gra-1903	101	5	:	:	PUNCT
gra-1903	101	6	10.36106	10.36106	NUM
gra-1903	101	7	/	/	SYM
gra-1903	101	8	gjra	gjra	NOUN